<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Genome Biol</journal-id>
    <journal-id journal-id-type="iso-abbrev">Genome Biol</journal-id>
    <journal-title-group>
      <journal-title>Genome Biology</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1474-7596</issn>
    <issn pub-type="epub">1474-760X</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8638120</article-id>
    <article-id pub-id-type="publisher-id">2538</article-id>
    <article-id pub-id-type="doi">10.1186/s13059-021-02538-1</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Method</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Functional enrichment of alternative splicing events with NEASE reveals insights into tissue identity and diseases</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Louadi</surname>
          <given-names>Zakaria</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Elkjaer</surname>
          <given-names>Maria L.</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Klug</surname>
          <given-names>Melissa</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff6">6</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Lio</surname>
          <given-names>Chit Tong</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Fenn</surname>
          <given-names>Amit</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Illes</surname>
          <given-names>Zsolt</given-names>
        </name>
        <xref ref-type="aff" rid="Aff3">3</xref>
        <xref ref-type="aff" rid="Aff4">4</xref>
        <xref ref-type="aff" rid="Aff5">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Bongiovanni</surname>
          <given-names>Dario</given-names>
        </name>
        <xref ref-type="aff" rid="Aff6">6</xref>
        <xref ref-type="aff" rid="Aff7">7</xref>
        <xref ref-type="aff" rid="Aff8">8</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Baumbach</surname>
          <given-names>Jan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff9">9</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kacprowski</surname>
          <given-names>Tim</given-names>
        </name>
        <xref ref-type="aff" rid="Aff10">10</xref>
        <xref ref-type="aff" rid="Aff11">11</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
        <name>
          <surname>List</surname>
          <given-names>Markus</given-names>
        </name>
        <address>
          <email>markus.list@wzw.tum.de</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
        <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7592-2080</contrib-id>
        <name>
          <surname>Tsoy</surname>
          <given-names>Olga</given-names>
        </name>
        <address>
          <email>olga.tsoy@uni-hamburg.de</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.6936.a</institution-id><institution-id institution-id-type="ISNI">0000000123222966</institution-id><institution>Chair of Experimental Bioinformatics, TUM School of Life Sciences, </institution><institution>Technical University of Munich, </institution></institution-wrap>85354 Freising, Germany </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.9026.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2287 2617</institution-id><institution>Institute for Computational Systems Biology, </institution><institution>University of Hamburg, </institution></institution-wrap>Notkestrasse 9, 22607 Hamburg, Germany </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.7143.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 0512 5013</institution-id><institution>Department of Neurology, </institution><institution>Odense University Hospital, </institution></institution-wrap>Odense, Denmark </aff>
      <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.10825.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0728 0170</institution-id><institution>Institute of Clinical Research, </institution><institution>University of Southern Denmark, </institution></institution-wrap>Odense, Denmark </aff>
      <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.10825.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0728 0170</institution-id><institution>Institute of Molecular Medicine, </institution><institution>University of Southern Denmark, </institution></institution-wrap>Odense, Denmark </aff>
      <aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.6936.a</institution-id><institution-id institution-id-type="ISNI">0000000123222966</institution-id><institution>Department of Internal Medicine I, School of Medicine, </institution><institution>University hospital rechts der Isar, Technical University of Munich, </institution></institution-wrap>Munich, Germany </aff>
      <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.452396.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 5937 5237</institution-id><institution>German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, </institution></institution-wrap>Munich, Germany </aff>
      <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.417728.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 8807</institution-id><institution>Department of Cardiovascular Medicine, </institution><institution>Humanitas Clinical and Research Center IRCCS and Humanitas University, </institution></institution-wrap>Rozzano, Milan, Italy </aff>
      <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.10825.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0728 0170</institution-id><institution>Institute of Mathematics and Computer Science, </institution><institution>University of Southern Denmark, </institution></institution-wrap>Campusvej 55, 5000 Odense, Denmark </aff>
      <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="GRID">grid.6738.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 1090 0254</institution-id><institution>Division Data Science in Biomedicine, </institution><institution>Peter L. Reichertz Institute for Medical Informatics of Technische Universität Braunschweig and Hannover Medical School, </institution></institution-wrap>Braunschweig, Germany </aff>
      <aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="GRID">grid.6738.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 1090 0254</institution-id><institution>Braunschweig Integrated Centre of Systems Biology (BRICS), </institution><institution>TU Braunschweig, </institution></institution-wrap>Braunschweig, Germany </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>2</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>2</day>
      <month>12</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2021</year>
    </pub-date>
    <volume>22</volume>
    <elocation-id>327</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>7</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>10</day>
        <month>11</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">Alternative splicing (AS) is an important aspect of gene regulation. Nevertheless, its role in molecular processes and pathobiology is far from understood. A roadblock is that tools for the functional analysis of AS-set events are lacking. To mitigate this, we developed NEASE, a tool integrating pathways with structural annotations of protein-protein interactions to functionally characterize AS events. We show in four application cases how NEASE can identify pathways contributing to tissue identity and cell type development, and how it highlights splicing-related biomarkers. With a unique view on AS, NEASE generates unique and meaningful biological insights complementary to classical pathways analysis.</p>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s13059-021-02538-1.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Alternative splicing</kwd>
      <kwd>Differential splicing</kwd>
      <kwd>Functional enrichment</kwd>
      <kwd>Systems biology</kwd>
      <kwd>Protein-protein interactions</kwd>
      <kwd>Disease pathways</kwd>
      <kwd>Platelet activation</kwd>
      <kwd>Multiple sclerosis</kwd>
      <kwd>Dilated cardiomyopathy</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id>
            <institution>bundesministerium für bildung und forschung</institution>
          </institution-wrap>
        </funding-source>
        <award-id>01zx1908a</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>Universität Hamburg (1037);</institution>
        </funding-source>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2021</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par2">Alternative splicing (AS) boosts transcript diversity in human cells [<xref ref-type="bibr" rid="CR1">1</xref>] and thus contributes to tissue identity [<xref ref-type="bibr" rid="CR2">2</xref>], cell development [<xref ref-type="bibr" rid="CR3">3</xref>], and pathology in, e.g., cardiomyopathy [<xref ref-type="bibr" rid="CR4">4</xref>], muscular dystrophy [<xref ref-type="bibr" rid="CR5">5</xref>], or autoimmune diseases [<xref ref-type="bibr" rid="CR6">6</xref>]. It is estimated that up to 30% of disease-associated genetic variants affect splicing [<xref ref-type="bibr" rid="CR7">7</xref>]. RNA sequencing technologies (RNA-seq) allow the quantification of different types of AS events and detect splicing abnormalities in disorders. However, RNA-seq utility is currently limited by our incomplete understanding of the functional role of specific exons or the transcripts they contribute to.</p>
    <p id="Par3">A major challenge in AS analysis is the functional interpretation of a set of events, including isoform switching events and differentially spliced exons. The usual approach is to perform gene set enrichment or overrepresentation analysis [<xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. This approach treats all genes affected by AS equally, neglecting that some AS events may not be functionally relevant at the protein level [<xref ref-type="bibr" rid="CR11">11</xref>] or result from noise in the splicing machinery [<xref ref-type="bibr" rid="CR12">12</xref>]. Furthermore, functional differences between protein isoforms remain uncertain in many cases. A promising strategy to identify relevant AS events is to focus on those that lead to meaningful changes in the protein structure. Recent studies have shown that AS has the potential to rewire protein-protein interactions by affecting the inclusion of domain families [<xref ref-type="bibr" rid="CR13">13</xref>] and linear motifs [<xref ref-type="bibr" rid="CR14">14</xref>] or by activating nonsense-mediated decay [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
    <p id="Par4">This motivated the creation of databases and tools that predict the consequences of individual AS events or isoform switches. IsoformSwitchAnalyzeR [<xref ref-type="bibr" rid="CR16">16</xref>], tappAS [<xref ref-type="bibr" rid="CR17">17</xref>], DoChaP [<xref ref-type="bibr" rid="CR18">18</xref>], and Spada [<xref ref-type="bibr" rid="CR19">19</xref>] support transcript-level (as opposed to exon-level) analysis to identify isoform switches and their impact on the translation and the resulting isoforms features, such as domains, motifs, and non-coding sites. Exon Ontology [<xref ref-type="bibr" rid="CR20">20</xref>] and DIGGER [<xref ref-type="bibr" rid="CR21">21</xref>] support exon-level analysis to identify exon skipping events and their possible impact on the protein structure and function. Spada and DIGGER further consider the impact of AS on protein-protein interactions.</p>
    <p id="Par5">Most existing tools allow investigating AS-driven changes in an explorative fashion but tools for systematic analysis of functional effects of AS are lacking. Exon Ontology performs statistical tests to identify enriched features within a set of skipped exons. One example is domain families affected by AS across proteins more frequently than expected. However, none of the existing tools offer a systems biology view to specifically highlight functional consequences of AS events.</p>
    <p id="Par6">To tackle these limitations, we developed the first tool for functional enrichment of AS events. NEASE (Network-based Enrichment method for AS Events) first detects protein domains affected by AS and then uses protein-protein interactions (PPI) integrated with domain-domain interactions (DDI) [<xref ref-type="bibr" rid="CR21">21</xref>], residue-level, and domain-motif interactions (DMI) [<xref ref-type="bibr" rid="CR22">22</xref>] to identify interaction partners likely affected by AS. Next, it employs an edge-level hypergeometric test for gene set overrepresentation analysis. This approach is new in the way genes are selected for the enrichment test. Rather than considering only differentially spliced or expressed genes, which is currently the most common strategy, NEASE uses network information to select genes that are likely affected in the interactome. This is also superior to a simple network enrichment analysis, as we consider only those edges for which an AS contribution seems relevant and for which false positive results are less likely. We evaluated NEASE using multiple datasets from both healthy and disease cohorts. We show that the NEASE approach complements gene-level enrichment, and even outperforms it in scenarios where gene-level enrichment fails to find relevant pathways. Moreover, NEASE generates unique and meaningful biological insights on the exact impact of AS. Furthermore, since the statistical approach is network-based, NEASE can prioritize (differentially) spliced genes and find new disease biomarkers candidates in case of aberrant splicing. The NEASE Python package, freely available at https://github.com/louadi/NEASE, provides multiple functions for a deeper analysis and visualization of affected protein domains, edges, and pathways (individually or as a set).</p>
  </sec>
  <sec id="Sec2">
    <title>Results</title>
    <sec id="Sec3">
      <title>Overview of NEASE</title>
      <p id="Par7">NEASE uses a hybrid approach that combines biological pathways with PPIs and DDIs to perform functional enrichment of AS. First, we use the structural annotation of known isoforms by mapping protein domains from the Pfam database [<xref ref-type="bibr" rid="CR23">23</xref>] to the corresponding exons (Fig. <xref rid="Fig1" ref-type="fig">1</xref>A). Second, we construct a structural joint graph as previously reported [<xref ref-type="bibr" rid="CR21">21</xref>] by enriching the BioGRID PPI [<xref ref-type="bibr" rid="CR24">24</xref>] with DDIs (from DOMINE [<xref ref-type="bibr" rid="CR25">25</xref>] and 3did [<xref ref-type="bibr" rid="CR26">26</xref>]), DMIs from the Eukaryotic Linear Motif resource (ELM) [<xref ref-type="bibr" rid="CR22">22</xref>], and interface residues from the Protein Data Bank (PDB) [<xref ref-type="bibr" rid="CR27">27</xref>] (see Methods). In the joint graph, protein features such as domains, motifs, and residues are mapped to their mediated interactions. Thus, NEASE provides an exon-centric view of the interactome and addresses the limited exon-level annotation. Exons are represented by the features they encode, and interactions between features are represented by edges. In this way, the impact of AS can be seen as an edgetic change in the network. Analyzed AS events are viewed as a set of affected edges that represent gained or lost PPIs.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Overview of NEASE. <bold>A</bold> Annotated exons are mapped to Pfam domains, motifs, and residues. The joint graph of PPIs, DDIs, DMIs, and co-resolved structure is used to identify the interactions mediated by these features. <bold>B</bold> For a list of exons/events, NEASE identifies interactions mediated by the spliced protein features and pathways that are significantly affected by those interactions. <bold>C</bold> NEASE provides a corrected <italic>p</italic> value, in addition to an enrichment score (NEASE Score) for every pathway (see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section). The user can further focus on an individual pathway, where NEASE can prioritize genes and find new biomarkers. In this example, the gene G3 was not part of the enriched pathway A but it has the largest number of affected interactions with genes from the pathway</p></caption><graphic xlink:href="13059_2021_2538_Fig1_HTML" id="MO1"/></fig></p>
      <p id="Par8">We then perform statistical tests to find enriched pathways and most likely responsible genes (Fig. <xref rid="Fig1" ref-type="fig">1</xref>B). Following, (differential) splicing analysis, a one-sided hypergeometric test is used to test for enrichment of a given pathway or gene set by considering all edges affected by AS in an experiment. A similar test is applied for each spliced gene to prioritize the most relevant events/genes that are affecting a pathway. We further introduce a weighted score (NEASE score) that penalizes hub nodes that are more likely to be connected to the pathway of interest by chance. Notably, this approach also considers genes that are not part of the existing pathway definition but show a significant number of interactions with the pathway, highlighting new putative biomarkers (see Methods and Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6, for details).</p>
      <p id="Par9">The Python package provides an interactive analysis. Using a list of exons or events, users can run a general enrichment on 12 different pathway databases (collected from the ConsensusPathDB resource [<xref ref-type="bibr" rid="CR28">28</xref>]), followed up by a specific analysis and visualization for a single affected pathway or module of interest (Fig. <xref rid="Fig1" ref-type="fig">1</xref>C). To provide analysis for individual isoforms and events, we linked NEASE to our previously developed database DIGGER, which provides an isoform- and exon-centric view of the interactome [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
      <p id="Par10">To check if the structurally annotated PPI is more biased to hubs than the standard PPI network, we computed the node degree distribution of the network before and after filtering for the structure evidence. As shown in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S1, the two histograms show similar trends with an overall smaller number of edges in the structurally annotated PPI. The latter has a maximum node degree equal to 424, compared to 2887 in the full PPI. This observation shows that the structurally annotated PPI does not increase the bias towards hub genes of the interactome.</p>
    </sec>
    <sec id="Sec4">
      <title>NEASE gives insights into the role of the muscle- and neural-specific exons</title>
      <p id="Par11">Recent studies suggest that the regulation of AS occurs in a tissue-specific manner and leads to remodeling of protein-protein interactions [<xref ref-type="bibr" rid="CR29">29</xref>]. Understanding the functional impact of co-regulated exons is critical in understanding gene regulation. We applied NEASE to tissue-specific exons reported in VastDB, a resource that provides information on multiple types of AS events detected by RNA-seq from different tissue types and developmental stages [<xref ref-type="bibr" rid="CR30">30</xref>]. We extracted 2831 exon skipping events and Percent Spliced In values (PSI) from 12 different human tissue types (Additional file <xref rid="MOESM7" ref-type="media">7</xref>, see Methods). We then performed hierarchical clustering on the <italic>z</italic> score standardized PSI values (Fig. <xref rid="Fig2" ref-type="fig">2</xref>A). The heatmap shows two distinct clusters, where neural-specific and muscle-specific (merged with heart-specific) exons are dominant.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Analysis of tissue-specific exons. <bold>A</bold> Heatmap and hierarchical clustering of standardized PSI values obtained from VastDB. The heatmap only shows events with a standard deviation of PSI values ≥ 20. The heatmap shows that clusters of exons upregulated in neural tissues and muscle/heart tissues are dominant (clusters C1 and C3). <bold>B</bold> NEASE analysis shows that 28% and 27% for both neural and muscle upregulated exons, respectively, are encoding protein features: domains, linear motifs, and residues. For these subgroups of events, the exact protein complexes involved can be identified, and NEASE enrichment can be performed. <bold>C</bold>, <bold>D</bold> Comparison between gene-level enrichment and NEASE enrichment for the two sets of exons</p></caption><graphic xlink:href="13059_2021_2538_Fig2_HTML" id="MO2"/></fig></p>
      <p id="Par12">Next, we extracted 56 skipped exons with a high PSI in the muscle tissues and 62 skipped exons with a high PSI in the neural tissues (<italic>z</italic> score ≥ + 2, see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section). We checked how many of these events are overlapping with protein features. As shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>B, 27% of the upregulated exons in muscle tissues (13) and 28% of the upregulated exons in the neural tissues (17) overlap with protein features. NEASE also provides statistics of how many of these domains have known binding partners in the joint graph. In the two sets, around 60% of the affected domains have known interactions in our joint graph: 8 binding domains in the muscle tissues and 10 binding domains in the neural tissues (Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Tables S4, S5 and Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Tables S8, S9). We further identified one affected motif in the gene ATP2B1 in neural exons. For these groups of events, the exact protein complexes involved can be identified, and NEASE statistical analysis can be performed to determine affected pathways. However, it is important to keep in mind that not all affected domains are necessarily interacting domains but could also be regulating gene expression by binding to DNA or RNA [<xref ref-type="bibr" rid="CR31">31</xref>].</p>
      <p id="Par13">First, we ran a gene set overrepresentation analysis (one-sided hypergeometric test), which we refer to as gene-level enrichment, to detect enriched pathways (see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section). Next, we applied NEASE to the same genes to detect pathways affected by AS. Unlike the gene-level enrichment, the results obtained from NEASE in both sets better explain the functional role of the regulated exons (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C, D). We also compared with the results from the Network Enrichment Analysis method NEA [<xref ref-type="bibr" rid="CR32">32</xref>]. NEA is a PPI-based approach that considers all edges for statistical tests. In contrast, NEASE considers only AS-affected edges. For a fair comparison, we run NEA with the same PPI network (BioGRID) and same pathways databases (see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section). The results of NEA did not improve over the classic gene-level enrichment (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S2), which suggests that our exon-specific approach helps to narrow down the exact complexes/pathways affected by AS and reduces false positives.</p>
      <p id="Par14">To further validate the robustness of the enrichment obtained by NEASE, we further conducted permutation tests. Here, our null hypothesis is that the tissue-specific exons are not different from a random set of exons in terms of the quality of the functional enrichment (measured as the <italic>p</italic> values of the hypergeometric test). For a more realistic scenario, our background set of exons considers only exon skipping events that can actually be found in these tissues (see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section for details). This approach will also help evaluate our methods against known and unknown biases. The empirical <italic>p</italic> values of the permutation test, which indicate the chance of finding an enrichment <italic>p</italic> value as low or lower than the one reported by NEASE, are 0.0008 and 0.0001 for neural and muscles upregulated exons, respectively. These results further demonstrate the robustness of our analysis.</p>
      <p id="Par15">The upregulated exons in heart and muscle tissues were enriched in “Muscle Contraction” pathways (Fig. <xref rid="Fig2" ref-type="fig">2</xref>C and Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S7 ), while, in the gene-level enrichment, the pathways were related to very common subcellular functions such as the Golgi apparatus, which also is an organelle for collecting, modifying or destroying protein products (Fig. <xref rid="Fig2" ref-type="fig">2</xref> C and Additional file <xref rid="MOESM2" ref-type="media">2</xref>: Table S6). NEASE provides detailed information about the affected domains and their interaction partners (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1). The domain Tropomyosin (Pfam id: PF00261), which is part of the gene TPM1, e.g., is involved in the regulation of muscle contraction via actin and myosin. GAS2 (Pfam id: PF02187) is a domain of DST, a dystonin encoding gene, which plays a role in maintaining the integrity of the cytoskeleton. AS affects its binding with the gene CALM1 that encodes a calcium-binding protein involved in various calcium-dependent pathways like muscle contraction [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
      <p id="Par16">The exons upregulated in neural tissues showed enrichment in the synaptic vesicle cycle pathway responsible for the communication between neurons (Fig. <xref rid="Fig2" ref-type="fig">2</xref>D). Gene-level enrichment performed on par with NEASE, resulting in the same pathway but with a lower rank and significance (adjusted <italic>p</italic> values: 1.494631e−16 using NEASE and 0.0039 using gene-level, Additional file <xref rid="MOESM3" ref-type="media">3</xref>: Tables S10 and S11). Notably, NEASE also detected an enrichment in “oxidative phosphorylation”, which is the initiator for powering all major mechanisms mediating brain information processing [<xref ref-type="bibr" rid="CR34">34</xref>]. The neuron’s energy demands are remarkable both in their intensity and in their dynamic range and quick changes [<xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR38">38</xref>]. Therefore, AS could modify oxidative phosphorylation to serve tissue-specific needs. Experimental studies have also found that several key enzymes in “oxidative phosphorylation” are spliced, e.g., pyruvate kinase (PKM) that shifts from the PKM2 to the PKM1 isoform [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. NEASE also provides a detailed view on the affected mechanisms, such as an exon skipping event in the gene ATP6V0A1 overlapping with the V_ATPase_I domain (PFAM id: PF01496) and affecting the binding with seven other proteins from the complex vacuolar ATPase (V-ATPase) (<italic>p</italic> value: 5.853289e−17, Fig. <xref rid="Fig3" ref-type="fig">3</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S2 ). V-ATPase is required for synaptic vesicle exocytosis [<xref ref-type="bibr" rid="CR41">41</xref>] The a1-subunit of the V0 domain in ATP6V0A1 was recently shown to be highly expressed in neurons and to be essential for human brain development [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>]. In another example, NEASE identified two co-regulated events of the genes CLTA and CLTB (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). CLTA and CLTB genes are involved in Clathrin-dependent endocytosis which forms clathrin-coated vesicles. Both genes play a major role in forming the protein complex of the coated vesicle. Both events affect the same domain Clathrin light chain (Pfam id: PF01086). The Clathrin light chain domain binds to CLTC and CLTCL1 which are the Clathrin heavy chain genes (<italic>p</italic> value: 6.943483e−05). These results suggest that the formation of this complex is co-regulated by AS. A similar finding about the role of the Clathrin light chain in neurons was also described in [<xref ref-type="bibr" rid="CR44">44</xref>]. NEASE highlights these co-regulated events at the network level (Fig. <xref rid="Fig3" ref-type="fig">3</xref>). As a sanity check, we manually checked the PSI values of these critical events identified by NEASE in the Genotype-Tissue Expression data set (GTEx), a comprehensive resource for tissue-specific gene expression and regulation [<xref ref-type="bibr" rid="CR45">45</xref>]. VastDB includes the quantification of PSI values from 8378 samples (49 tissues and 543 individuals) from GTEx version 6 on their website (<ext-link ext-link-type="uri" xlink:href="https://vastdb.crg.eu/">https://vastdb.crg.eu/</ext-link>). As shown in the examples in Additional file <xref rid="MOESM1" ref-type="media">1</xref> Figures S4 and S5, the exons are confirmed to be highly upregulated in their respective tissues. The analysis generated from VastDB using NEASE agrees with the latest studies at transcriptomics and proteomics levels that emphasize the crucial role of AS in the function and development of brain and heart tissues [<xref ref-type="bibr" rid="CR46">46</xref>–<xref ref-type="bibr" rid="CR48">48</xref>].
<fig id="Fig3"><label>Fig. 3</label><caption><p>NEASE visually highlights the impact of the AS regulation at the interactome level. The gray nodes represent proteins from the pathway and the red nodes represent genes with AS events. Red edges represent the affected interactions for the nodes with known DDIs, DMIs, or co-resolved structures. The visualization of the pathway “Synaptic vesicle cycle” from the KEGG database for the exons upregulated in the neural tissues shows that the splicing in the genes CLTA and CLTB is co-regulated and affects the interactions of the same complex. Similarly, NEASE highlights the importance of the domain ATP6V0A1 which is upregulated in neural tissues and binds seven proteins from the “Synaptic vesicle cycle” pathway</p></caption><graphic xlink:href="13059_2021_2538_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
    <sec id="Sec5">
      <title>NEASE reveals splicing-related differences of reticulated and mature platelets</title>
      <p id="Par17">AS does not only drive tissue-specific regulation but also plays a major role in cell differentiation and maturation. To illustrate an example of the utility of NEASE in such studies, we used the RNA-seq data set from [<xref ref-type="bibr" rid="CR49">49</xref>] which compares the transcriptome profiles of reticulated platelets and mature platelets from healthy donors. Reticulated platelets are younger [<xref ref-type="bibr" rid="CR50">50</xref>], larger in size, and contain more RNA [<xref ref-type="bibr" rid="CR51">51</xref>]. Moreover, they have a prothrombotic potential and are known to be more abundant in patients with diabetes, acute or chronic coronary syndrome, and in smokers [<xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR53">53</xref>]. Additionally, elevated levels of reticulated platelets in peripheral blood are predictors of insufficient response to antiplatelet therapies (e.g., aspirin and P2Y12 inhibitors) and are promising novel biomarkers for the prediction of adverse cardiovascular events in different pathological settings [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]. A strong enrichment of pro-thrombotic signaling in reticulated platelets was observed in healthy donors [<xref ref-type="bibr" rid="CR49">49</xref>]. Comparative transcriptomic analysis revealed a differential expression of several pathways in addition to an enrichment of prothrombotic pathways and transcripts of transmembrane proteins as the collagen receptor GPVI, the thromboxane receptor A2 and the thrombin receptors PAR1 and PAR4. Gene set enrichment analysis indicated an upregulation of entire prothrombotic activation pathways as the thrombin PAR1 and integrin GPIIb/IIIa signaling pathway in reticulated platelets.</p>
      <p id="Par18">Since AS has been described to occur in platelets [<xref ref-type="bibr" rid="CR55">55</xref>], we wanted to investigate the splicing patterns between the previously defined reticulated and mature platelet subgroups. Using MAJIQ [<xref ref-type="bibr" rid="CR56">56</xref>] (see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section), we found 169 differentially spliced genes. From 25 affected protein domains, 17 have known interactions (68% of affected domains, Fig. <xref rid="Fig4" ref-type="fig">4</xref>A, Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Tables S12 and S13). Other affected protein features include 6 residues involved in PPIs and one linear motif in the gene PAWR.
<fig id="Fig4"><label>Fig. 4</label><caption><p><bold>A</bold> 15 % of differentially spliced exons, between reticulated and mature platelets, are known to encode protein features. For this subset of exons, NEASE enrichment can be performed. <bold>B</bold> Gene level enrichment of all differentially spliced exons in the Reactome database fails to capture the most relevant pathways. <bold>C</bold> In contrast, NEASE shows an enrichment of the GPCR downstream signaling and other related pathways that are well known to be important in platelet activation. <bold>D</bold> A further look at the genes driving the enrichment of the GPCR pathway shows the most relevant genes affected by AS</p></caption><graphic xlink:href="13059_2021_2538_Fig4_HTML" id="MO4"/></fig></p>
      <p id="Par19">We observed that the enrichment at the gene-level using the Reactome [<xref ref-type="bibr" rid="CR57">57</xref>] database ranks general cellular pathways higher, including “Membrane Trafficking” and “Vesicle-mediated transport,” and “Golgi-to-ER retrograde transport.” An exception is the “Circadian Clock” pathway, which is hypothesized to be related to platelet activation [<xref ref-type="bibr" rid="CR58">58</xref>] (Fig. <xref rid="Fig4" ref-type="fig">4</xref>B). The pathway “Platelet activation, signaling and aggregation” was less significant in gene-level enrichment (adjusted <italic>p</italic> value: 0.061, Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S14) compared to NEASE enrichment (adjusted <italic>p</italic> value: 0.004, Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S15). Using NEASE, we obtained more meaningful results and unique pathways. As shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>C, the most significant pathways in reticulated platelets are G Protein-Coupled Receptor-related. G proteins are essential in the second phase of platelet-dependent thrombus formation [<xref ref-type="bibr" rid="CR59">59</xref>]. Furthermore, GPCR isoforms are known to have distinct signaling properties [<xref ref-type="bibr" rid="CR60">60</xref>]. Other relevant pathways associated with platelet activation are “Hemostasis,” “Thromboxane signaling through tp receptor,” and “Platelet homeostasis.” The full tables for enrichment at the gene level and using NEASE are available in the Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Tables S14 and S15. The upregulation of these pathways in reticulated platelets emphasizes their previously described prothrombotic phenotype and their involvement in several downstream signaling processes.</p>
      <p id="Par20">We also looked at the individual AS events driving this enrichment. For each affected feature, NEASE tests if it significantly interacts with the GPCR downstream signaling pathway (Additional file <xref rid="MOESM4" ref-type="media">4</xref>: Table S16, see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section). Figure <xref rid="Fig4" ref-type="fig">4</xref>C illustrates affected genes and their <italic>p</italic> value ranking. The top gene is GNAQ (G-protein subunit alpha q), which is known to be involved in signal transduction in platelets leading to platelet activation [<xref ref-type="bibr" rid="CR61">61</xref>]. The regulation of the G-protein alpha subunit can be an indication that compared to mature platelets, reticulated platelets are more involved in various signal transduction pathways related to, e.g., pro-thrombotic processes [<xref ref-type="bibr" rid="CR51">51</xref>]. PRKCA, which also showed different splicing patterns between the two platelet subgroups, plays a major role in the platelet formation process by modulating platelet function [<xref ref-type="bibr" rid="CR62">62</xref>], megakaryocyte function, and development [<xref ref-type="bibr" rid="CR63">63</xref>] and negatively regulates pro-platelet formation [<xref ref-type="bibr" rid="CR64">64</xref>]. Moreover, the regulation of PRKCA binding in reticulated platelets might refer to the young nature of reticulated platelets, which have undergone the pro-platelet formation process more recently than mature platelets [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR65">65</xref>].</p>
    </sec>
    <sec id="Sec6">
      <title>NEASE characterizes complex disorders such as Multiple Sclerosis</title>
      <p id="Par21">Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system. Early in the disease course, MS is characterized by focal lesions in the brain induced by an influx of systemic inflammatory cells. These active lesions infiltrated by immune cells and activated microglia are characterized by inflammatory demyelination and axonal loss [<xref ref-type="bibr" rid="CR66">66</xref>]. The surrounding white matter tissue is termed normal-appearing white matter due to diffuse pathology without focal lesion activity and dense immune activity [<xref ref-type="bibr" rid="CR67">67</xref>]. The etiology of MS remains unknown. Recently, a systematic literature review found 27 genes that were alternatively spliced in MS patients [<xref ref-type="bibr" rid="CR68">68</xref>].</p>
      <p id="Par22">We used RNA-Seq of macrodissected areas from postmortem white matter tissue of patients with progressive MS [<xref ref-type="bibr" rid="CR69">69</xref>]. We compared normal-appearing white matter and active lesions regions from postmortem white matter brains of MS patients. We found 109 differentially spliced genes with 19 affected domains and one linear motif with known interactions, in addition to 6 known interacting residues. In total, NEASE identified 156 affected interactions (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Tables S17 and S18).</p>
      <p id="Par23">Gene-level enrichment ranks high pathways likely irrelevant that are involved in muscle contraction, cardiac conduction, and membrane trafficking, with the exception of Ca2+ ion flow across membranes (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S19). Ca2+ is an essential signal molecule for all cell activity. Although deregulation of calcium signaling is related to the pathogenesis of multiple diseases [<xref ref-type="bibr" rid="CR70">70</xref>], including neurological disorders [<xref ref-type="bibr" rid="CR71">71</xref>], it is not specific to neuronal tissues. In line with the neurodegenerative and immune-mediated features of MS, NEASE found unique enriched pathways related to brain network signaling and neuronal pathways “Neurotransmitter receptors and postsynaptic signal transmission,” “Transmission across Chemical Synapses,” “Activation of NMDA receptor and postsynaptic events,” “MAPK family signaling cascades,” “Neuronal System”), as well as pathways related to immune responses (“interleukin-17 signaling,” “Toll-Like Receptor 10 (TLF10) Cascade”) (Table <xref rid="Tab1" ref-type="table">1</xref> and Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S20). Two other pathways were related to the uptake of anthrax or bacterial toxins. This could be a result of clean-up from toxic inflammatory processes or increased presence of invaders due to the leaky brain-blood-barrier in MS [<xref ref-type="bibr" rid="CR72">72</xref>–<xref ref-type="bibr" rid="CR74">74</xref>]. Additionally, it also supports the theory of infections as the trigger of lesion damage in MS [<xref ref-type="bibr" rid="CR75">75</xref>].
<table-wrap id="Tab1"><label>Table 1</label><caption><p>NEASE enrichment obtained from AS comparison between normal-appearing white matter and acute lesions, from multiple sclerosis patients. The highly enriched pathways belong to Neurotransmitter receptors, MAPK, and bacterial infection. Most of these pathways are hallmarks of MS. The NEASE score is obtained after combining the <italic>p</italic> value with the number of significant genes. The latter is obtained after individual tests for each gene in the column “Spliced genes” (see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Pathway name</th><th>Spliced genes (number of interactions affecting the pathway)</th><th><bold><italic>p</italic></bold> value</th><th>adj <bold><italic>p</italic></bold> value</th><th>NEASE score</th></tr></thead><tbody><tr><td>Neurotransmitter receptors and postsynaptic signal transmission</td><td>GRIA1 (7), ATP2B1 (2), BRAF (4), MAP2K4 (1), GRIN1 (4)</td><td>4.38e−09</td><td>0.000004</td><td>16.71</td></tr><tr><td>Uptake and function of anthrax toxins</td><td>ATP2B1 (1), BRAF (5), MAP2K4 (3)</td><td>2.98e−09</td><td>0.000004</td><td>14.76</td></tr><tr><td>Transmission across chemical synapses</td><td>GRIA1 (7), ATP2B1 (2), BRAF (4), MAP2K4 (1), GRIN1 (4)</td><td>5.65e−08</td><td>0.000010</td><td>14.49</td></tr><tr><td>Uptake and actions of bacterial toxins</td><td>ATP2B1 (1), BRAF (5), MAP2K4 (3)</td><td>3.46e−08</td><td>0.000009</td><td>12.92</td></tr><tr><td>Neuronal system</td><td>GRIA1 (7), ATP2B1 (2), BRAF (4), MAP2K4 (1), GRIN1 (4)</td><td>8.71e−07</td><td>0.000122</td><td>12.11</td></tr><tr><td>MAPK family signaling cascades</td><td>MYH10 (2), ATP2B1 (1), BRAF (17), MAP2K4 (5), GRIN1 (3)</td><td>1.52e−06</td><td>0.000184</td><td>10.07</td></tr><tr><td>Activation of NMDA receptor and postsynaptic events</td><td>GRIA1 (2), ATP2B1 (1), BRAF (4), MAP2K4 (1), GRIN1 (3)</td><td>2.12e−06</td><td>0.000241</td><td>9.82</td></tr><tr><td>FCERI mediated MAPK activation</td><td>MYH10 (1), BRAF (7), MAP2K4 (8)</td><td>2.52e−07</td><td>0.000038</td><td>9.33</td></tr><tr><td>RAF/MAP kinase cascade</td><td>MYH10 (1), ATP2B1 (1), BRAF (16), MAP2K4 (4), GRIN1 (3)</td><td>1.00e−06</td><td>0.000130</td><td>8.48</td></tr><tr><td>Signaling by moderate kinase activity BRAF mutants</td><td>MYH10 (1), BRAF (14), MAP2K4 (2)</td><td>8.30e−09</td><td>0.000004</td><td>8.08</td></tr></tbody></table></table-wrap></p>
      <p id="Par24">As shown in Table <xref rid="Tab1" ref-type="table">1</xref>, the pathway “Uptake and function of anthrax toxins” has the best overall adjusted <italic>p</italic> value, calculated only based on the total number of edges affecting the pathway. When we also included the number of significant genes and calculated NEASE scores (see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section), NEASE ranks the pathway “Neurotransmitter receptors and postsynaptic signal transmission” first, and moves pathways such as “Transmission across Chemical Synapses” and “Neuronal System” higher in the rank. These observations illustrate the usefulness of the NEASE score as a complement to the global edge-based enrichment.</p>
      <p id="Par25">Two of the most significant genes in the “Neurotransmitter receptors” pathway were GRIN1 and GRIA1 (Additional file <xref rid="MOESM5" ref-type="media">5</xref>: Table S21). GRIN1 encodes GluN1, which is one of the two obligatory subunits for the NMDAR1 receptor, whereas GRIA1 encodes the AMPAR1 subunit. Their ligand is glutamate, and they are both ionotropic receptors and have been associated with MS disease severity [<xref ref-type="bibr" rid="CR76">76</xref>–<xref ref-type="bibr" rid="CR78">78</xref>]. Interestingly, AS of MAP2K4 appeared in both brain-related and immune-related pathways, significantly enriched in active lesions <italic>vs</italic> normal-appearing white matter (Table <xref rid="Tab1" ref-type="table">1</xref>). MAP2K4 is a mitogen-activated protein kinase (MAPK) orchestrating multiple biological functions [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. AS of MAP2K4 has been found in rheumatoid arthritis [<xref ref-type="bibr" rid="CR81">81</xref>], as well as in pathways of patients with other autoimmune diseases [<xref ref-type="bibr" rid="CR82">82</xref>]. MS also precedes autoimmune attack, and therefore AS of MAP2K4 in active lesions detected with NEASE may represent dysregulated immune responses originating from the infiltrating immune cells or inflammatory-activated brain cells. This is supported by previous studies that found <italic>(i)</italic> overactivity of MAPK pathways in microglia (the resident immune cell of the brain) during neurodegeneration [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>], and <italic>(ii)</italic> increased phosphorylation of MAPK kinases in the systemic immune cells of MS patients [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>]. A recent study also characterized activated MS-specific pathways in immune cells from blood using phosphoproteomics. Here, MAP2K4 and its interaction partners (e.g., TAK1) were present in MS-specific signaling activity [<xref ref-type="bibr" rid="CR87">87</xref>]. Future functional studies on the AS of MAP2K4 may help explain if AS could be the reason for increased phosphorylation and overactivity detected in MS. AS of MAP2K4 could result in switching protein conformation, increasing susceptibility to phosphorylation, or changing the downstream protein cascade.</p>
      <p id="Par26">With NEASE, we were able to specifically detect AS of genes and related pathways already known to be dysregulated within MS from excitotoxicity to inflammation. The detected AS genes in active lesions <italic>vs</italic> normal-appearing white matter demonstrate how major components in signaling activities may be fine-tuned/changed from regulation of a homeostatic state to an inflammatory state. Combining NEASE with functional experiments to understand the biological impact of AS could fuel new therapeutic opportunities for complex neurological diseases as MS. Novel developments in genome-editing tools and gene-specific strategies have made it possible to use antisense oligonucleotides or small modulators for splice modification. This is already used in the rare neuromuscular disease, spinal muscular atrophy, where an antisense oligonucleotide binds to a site near splicing to ensure the inclusion of an exon during the splicing event [<xref ref-type="bibr" rid="CR78">78</xref>].</p>
    </sec>
    <sec id="Sec7">
      <title>NEASE finds new biomarker candidates for dilated cardiomyopathy</title>
      <p id="Par27">AS might play a role in driving dilated cardiomyopathy (DCM) [<xref ref-type="bibr" rid="CR88">88</xref>]. DCM is a common heart muscle disease that is often diagnosed with structural abnormalities resulting in impaired contraction. Previous studies have shown a large number of differentially used exons in DCM patients [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. In this analysis, we used a list of 1212 differentially used exons between DCM patients and controls as reported by Heinig et al. [<xref ref-type="bibr" rid="CR10">10</xref>]. 29% of these exons overlap with protein features, including 230 domains and 15 linear motifs. (Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Tables S22 and S23). In this exon set, both the gene level enrichment and NEASE show very similar results (Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Tables S24 and S25). In both methods, we found that the list of exons was enriched in the dilated cardiomyopathy (DCM) pathway from KEGG, as well as, “Adrenergic signaling in cardiomyocytes” and “Regulation of actin cytoskeleton”.</p>
      <p id="Par28">In contrast to gene-level enrichment analysis, NEASE is able to score the contribution of alternatively spliced genes that are interacting with but are not part of the DCM pathway, allowing us to highlight putative biomarkers (Table <xref rid="Tab2" ref-type="table">2</xref>, Additional file <xref rid="MOESM6" ref-type="media">6</xref>: Table S26, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S3). The Myosin head domain from the gene MYO19 interacts with 6 other genes associated with DCM: (1) MYL2, which triggers contraction after Ca+ activation [<xref ref-type="bibr" rid="CR89">89</xref>]; (2–5) TPM1/TPM2/TPM3/TPM4, which encode the TPM protein—the main regulator of muscle contraction [<xref ref-type="bibr" rid="CR90">90</xref>]; and (6) ACTG, which encodes actin. Interestingly, MYO19 has not been investigated for its role in DCM, while its interacting genes are associated with DCM [<xref ref-type="bibr" rid="CR91">91</xref>–<xref ref-type="bibr" rid="CR94">94</xref>]. Additionally, the gene OBSCN has one affected interaction with the TTN gene [<xref ref-type="bibr" rid="CR95">95</xref>]. The TTN gene itself is also differentially spliced and associated with DCM [<xref ref-type="bibr" rid="CR95">95</xref>]. OBSCN was recently reported as a new DCM candidate [<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. Another interesting example is CACNA1C (Calcium Voltage-Gated Channel Subunit Alpha1 C), an already known DCM candidate [<xref ref-type="bibr" rid="CR98">98</xref>]. The differentially spliced exon overlaps with the domain Ion_trans (Pfam id: PF00520) which is essential for myocyte contraction [<xref ref-type="bibr" rid="CR99">99</xref>]. The affected interaction identified is with the ryanodine receptor 2 (RYR2). In striated muscles, the excitation-contraction coupling is mediated by this complex [<xref ref-type="bibr" rid="CR100">100</xref>]. Both CACNA1C and RYR2 are part of the KEGG DCM pathway [<xref ref-type="bibr" rid="CR101">101</xref>]. Alterations in ryanodine receptors were repeatedly reported to be related to heart failure [<xref ref-type="bibr" rid="CR102">102</xref>–<xref ref-type="bibr" rid="CR104">104</xref>].
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Enrichment of the pathway “Dilated cardiomyopathy (DCM)” from KEGG for the exons differentially used in DCM patients. The table shows the most significant genes (<italic>p</italic> value&lt; 0.05) (see the “<xref rid="Sec10" ref-type="sec">Methods</xref>” section)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Differentially spliced genes</th><th>DCM associated</th><th>Percentage of affected edges associated with DCM</th><th><bold><italic>P</italic></bold> value</th><th>Affected binding (edges) associated with DCM</th></tr></thead><tbody><tr><td>MYO19</td><td>No</td><td>6/51</td><td>0.000002</td><td>MYL2, TPM4, TPM3, TPM2, TPM1, ACTG</td></tr><tr><td>OBSCN</td><td>No</td><td>1/2</td><td>0.014</td><td>TTN</td></tr><tr><td>USP49</td><td>No</td><td>1/4</td><td>0.028</td><td>PRKACA</td></tr><tr><td>CACNA1C</td><td>Yes</td><td>1/4</td><td>0.028</td><td>RYR2</td></tr></tbody></table></table-wrap></p>
    </sec>
  </sec>
  <sec id="Sec8">
    <title>Discussion</title>
    <p id="Par29">In spite of its importance for biomarker and therapeutic target discovery, differential AS is still not a routine part of transcriptome analysis. A key reason for this could be the lack of suitable methods and software tools for AS-specific functional analysis. Our method NEASE closes this gap and provides a unique view on the impact of AS complementary to functional insights gained from traditional gene-level enrichment analysis. We applied NEASE to four diverse data sets and show that its results generate novel disease-relevant insights and provide valuable context to prior findings on altered RNA- and protein-expression levels consistent with recent literature.</p>
    <p id="Par30">In many cases, NEASE improves over gene-level enrichment analysis focusing on differentially spliced genes. One potential reason for this could be that not all AS events are necessarily functional [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. NEASE mitigates this by focusing on AS events that affect protein domains. However, it is important to keep in mind that this is not the only way to define functional AS events. AS also affects interacting disordered regions [<xref ref-type="bibr" rid="CR14">14</xref>] or facilitates nonsense-mediated decay [<xref ref-type="bibr" rid="CR105">105</xref>].</p>
    <p id="Par31">AS events could also lead to completely different functions or interactions [<xref ref-type="bibr" rid="CR106">106</xref>], e.g., two isoforms can have different interaction partners depending on the inclusion or loss of a single domain [<xref ref-type="bibr" rid="CR13">13</xref>]. Such changes in the interactome can not be captured with gene-level enrichment which has a strict focus on nodes rather than edges. With NEASE, we could show that integrating structural information at the exon level and PPI networks helps to identify the functional impact of differentially spliced and co-regulated exons. In practice, we consider both approaches as complementary and recommend running gene-level and edge-level enrichments together (both supported by the NEASE package). Note that while our analysis focuses on exon skipping events as the most studied event type, our method is generally agnostic to the event type.</p>
    <p id="Par32">NEASE relies on structurally annotated interactions and existing pathway annotations from databases such as KEGG [<xref ref-type="bibr" rid="CR101">101</xref>] and Reactome [<xref ref-type="bibr" rid="CR57">57</xref>]. Leveraging reliable structural information and established pathways likely removes many false positive PPI from considerations. While the structural annotations are generally of high quality, it should be noted that their coverage is still limited and, thus, the number of exons considered in our method is comparably low. For instance, the percentage of considered exons, in our example datasets, ranges between 15 and 30%, which is still far from being a global analysis of AS. Expanding the annotations at isoform-level and more widespread availability of structural information will greatly raise the usefulness of NEASE in the future. We also emphasize that while all events can potentially affect protein interactions on the domain level, not all AS events yield functional isoforms and other processes such as nonsense-mediated decay need to be considered as well. In the future, further progress is urgently needed to link transcriptomics and proteomics for better characterization and understanding of the exact impact of AS events. With our current approach, a large fraction of the PPI network remains unexplored, suggesting that adapting de novo network enrichment methods such as KeyPathwayMiner [<xref ref-type="bibr" rid="CR107">107</xref>] towards AS could be a promising research direction to uncover previously unknown disease mechanisms. NEASE currently considers the immediate neighborhood of a pathway in the PPI network. When carefully considering the expected increase in false positives, one could also increase the size of the pathway neighborhood using, e.g., a fixed radius for shortest paths. While these are attractive approaches, the biases of the PPI towards hubs, as well as the high number of false (or missing) edges of PPI, in its current form, make such approaches hard to control and statistically challenging. Even though NEASE is relatively conservative, we demonstrated that it is simple, robust, and generates meaningful and interpretable results. Thus, it provides an unprecedented opportunity to understand the functional impact of tissue-, developmental- and disease-specific AS in a system biology manner.</p>
  </sec>
  <sec id="Sec9">
    <title>Conclusions</title>
    <p id="Par33">While a plethora of gene set enrichment methods have been proposed in recent years, AS is typically not addressed specifically. Thus, NEASE closes an important gap in functional enrichment analysis of transcriptomics data. The analyses described here, confirm the widespread impact of AS in multiple biological processes and disorders. In the future, we plan to extend NEASE with further model organisms and to add structural annotations covering more types of AS events. Finally, we plan to integrate NEASE with the DIGGER web tool [<xref ref-type="bibr" rid="CR21">21</xref>] for seamless downstream analysis of AS in the web browser with the vision of establishing functional AS event analysis as a routine step in the transcriptomic analysis.</p>
  </sec>
  <sec id="Sec10">
    <title>Methods</title>
    <sec id="Sec11">
      <title>NEASE data sources</title>
      <p id="Par34">We construct a human structurally annotated PPI as described previously [<xref ref-type="bibr" rid="CR21">21</xref>]. Briefly, we integrate DDI and PPI information into a joint network where DDIs were obtained from 3did (v2019_01 [<xref ref-type="bibr" rid="CR26">26</xref>]) and DOMINE (v2.0 [<xref ref-type="bibr" rid="CR25">25</xref>] including high- and mid-confidence interactions) and PPIs were obtained from BioGRID 3.5 [<xref ref-type="bibr" rid="CR24">24</xref>]. In summary, out of 410,961 interactions from the human interactome 52,467 have at least one domain interaction. The linear motif instances and their interactions were downloaded from the ELM website and mapped to the respective exons. We found 3926 PPIs that are confirmed by at least one source of DMI. Position-specific PPI based on experimentally resolved structure from the PDB was obtained from [<xref ref-type="bibr" rid="CR21">21</xref>]. In total, 16,161 PPIs were enriched by at least one residue-level interaction. From the combination of all these resources the final structurally annotated graph contained in total 60,235 interactions. Each one of these interactions is annotated with one or multiple levels of evidence (DDIs, DMI, residues). The mapping of exons to their protein features was performed using the Biomart mapping table, Pfam, and ELM annotations [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>, <xref ref-type="bibr" rid="CR108">108</xref>]. We obtain the biological pathways with their gene list from KEGG [<xref ref-type="bibr" rid="CR57">57</xref>] and Reactome [<xref ref-type="bibr" rid="CR101">101</xref>] integrated into the ConsensusPathDB database [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
    </sec>
    <sec id="Sec12">
      <title>Statistical tests and pathway scores</title>
      <p id="Par35">Gene-level enrichment is performed using a hypergeometric test from the package GSEAPY (a Python wrapper for Enrichr [<xref ref-type="bibr" rid="CR109">109</xref>]) by considering all genes with (differential) AS events. Network enrichment analysis at the gene level was performed using the EviNet web server (www.evinet.org), which is an implementation of the randomization algorithm NEA [<xref ref-type="bibr" rid="CR32">32</xref>]. To achieve a fair comparison with NEASE, we run NEA using BioGRID as a PPI database and Reactome and KEGG as pathways references to match the exact conditions of the NEASE analysis.</p>
      <p id="Par36">For NEASE enrichment, we filtered the PPI graph <italic>G</italic>=(<italic>V</italic>, <italic>E</italic>), where <italic>V</italic> is the set of genes and <italic>E</italic> is the set of edges, to a subgraph <italic>G</italic>′=(<italic>V</italic>′, <italic>E</italic>′) containing only structurally annotated interactions <italic>E</italic>′ and their nodes <italic>V</italic>′. An interaction is considered structurally annotated if it is supported by at least one of these resources: domain-domain interactions, motif-domain interactions, or residue-level interactions. For a submitted query list of exons, NEASE first identifies affected domains, linear motifs, and residues that overlap with the exons and their interactions. Let <italic>N</italic> be two times the number of edges in <italic>G</italic>′ (the degree of the network) and n be the number of affected edges from the query. These edges are then considered using a test modified from [<xref ref-type="bibr" rid="CR110">110</xref>]. For every pathway <italic>P</italic> with degree <italic>K</italic>, let <italic>k</italic> be the number of affected edges that are connected to <italic>P</italic>. We model <italic>X</italic> whose outcome is <italic>k</italic> as a random variable following a hypergeometric distribution:
<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{X}\sim \mathrm{Hypergeometric}\left(\mathrm{n}=\mathrm{number}\ \mathrm{of}\ \mathrm{affected}\ \mathrm{edges},\mathrm{K}=\mathrm{degree}\ \mathrm{of}\ \mathrm{P},\mathrm{N}=\mathrm{degree}\ \mathrm{of}\ \mathrm{G}\hbox{'}\right) $$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mi mathvariant="normal">X</mml:mi><mml:mo>~</mml:mo><mml:mtext>Hypergeometric</mml:mtext><mml:mfenced close=")" open="(" separators=",,"><mml:mrow><mml:mi mathvariant="normal">n</mml:mi><mml:mo>=</mml:mo><mml:mtext>number of affected edges</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant="normal">K</mml:mi><mml:mo>=</mml:mo><mml:mtext>degree of</mml:mtext><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">P</mml:mi></mml:mrow><mml:mrow><mml:mi mathvariant="normal">N</mml:mi><mml:mo>=</mml:mo><mml:mtext>degree of</mml:mtext><mml:mspace width="0.25em"/><mml:mi mathvariant="normal">G</mml:mi><mml:mo>'</mml:mo></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="13059_2021_2538_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par37">where <italic>k</italic> is considered as the number of observed successes out of <italic>n</italic> draws, from a population of size <italic>N</italic> containing <italic>K</italic> success. Subsequently, NEASE tests if the number <italic>k</italic> is significant using a one-sided hypergeometric test (over-representation). In contrast to the test proposed in [<xref ref-type="bibr" rid="CR110">110</xref>], our test only includes structurally annotated edges and the ones likely to be impacted by AS in order to improve the signal-to-noise ratio. For illustration purposes, in the example of Fig. <xref rid="Fig1" ref-type="fig">1</xref>B, the overall number of affected edges by AS is <italic>n</italic>=7, and <italic>K</italic>=11 is the total degree of pathway <italic>A</italic> (11 possible success), the number of affected edges that are linked to the pathway is <italic>k</italic>=4. The enrichment <italic>p</italic> value of pathway A corresponds then to the significance of this last number. After testing for multiple pathways, the obtained <italic>p</italic> values for the edge-level enrichment are corrected, using the Benjamini-Hochberg method [<xref ref-type="bibr" rid="CR111">111</xref>]. The detailed pseudocode of this algorithm is explained in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6, Algorithm 1.</p>
      <p id="Par38">For a pathway of interest, a similar test can be applied to determine if a splicing event significantly affects interactions of a specific gene with this pathway (Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Figure S6, Algorithm 2 and Fig. <xref rid="Fig1" ref-type="fig">1</xref>B, C). Here, <italic>n</italic> is the number of all affected interactions (edges) of a spliced gene and <italic>k</italic> is the number of affected interactions (edges) across genes that are linked to the pathway of interest. In the example of Fig. <xref rid="Fig1" ref-type="fig">1</xref>B, C, the gene G2 can be connected to pathway <italic>A</italic> just by chance due to its high number of affected interactions. For this reason, it is ranked lower than the genes G3 and G4.</p>
      <p id="Par39">As a result, for every pathway, NEASE provides an overall <italic>p</italic> value, as well as the most significant genes. Since the <italic>p</italic> value only depends on the overall number of affected edges but not on the number of genes, the <italic>p</italic> value can be heavily influenced by hub genes. To reduce this influence, an optional score (NEASE Score, Eq.: 1) can be computed by NEASE to scale the natural logarithm of the <italic>p</italic> value with the total number of significant genes using a cutoff from the user (for instance <italic>p</italic> value ≤ 0.05):
<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \mathrm{NEASE}\ \mathrm{score}=-\sqrt{g}\times {\log}_{10}\left(p\;\mathrm{value}\right) $$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mtext>NEASE score</mml:mtext><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msqrt><mml:mi>g</mml:mi></mml:msqrt><mml:mo>×</mml:mo><mml:msub><mml:mo>log</mml:mo><mml:mn>10</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mi>p</mml:mi><mml:mspace width="0.12em"/><mml:mtext>value</mml:mtext></mml:mrow></mml:mfenced></mml:math><graphic xlink:href="13059_2021_2538_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par40">where <italic>g</italic> is the total number of significantly connected genes obtained after testing individual spliced genes. Thus, the NEASE Score prioritizes pathways that are affected by a larger number of spliced genes rather than pathways that have a larger number of affected interactions (edges). The user can choose to rank enrichment based on the adjusted <italic>p</italic> value or by the NEASE score.</p>
      <p id="Par41">For permutation tests, the set of highly confident 2831 exon skipping events obtained after the initial quality filtering is considered as the background set of exons. We compared the enrichment obtained in the pathways “Muscle Contraction” and “Synaptic vesicle cycle” from the set of exons upregulated in muscles/heart and neural tissues respectively, with 10,000 random sets of exons of the same size and then derived distribution of <italic>p</italic> values. The empirical <italic>p</italic> values were then obtained by asking how likely it is to obtain a <italic>p</italic> value as low or more extreme than the one reported by NEASE in the original set of neural and muscles upregulated exons.</p>
    </sec>
    <sec id="Sec13">
      <title>VastDB events processing</title>
      <p id="Par42">PSI values of the exon skipping events from VastDB were quantified by the developers using vast tools [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR112">112</xref>]. In our analysis, we extracted the PSI values for 32 experiments belonging to 12 main tissues: muscles/heart, neural (whole brain, cortex, and peripheral retina), placental, epithelial, digestive (colon and stomach), liver, kidney, adipose, testis, immune-hematopoietic, and ovary. We then filtered out the events with low read coverage (VLOW) and performed hierarchical clustering of standardized values (<italic>z</italic> scores). For every exon, we calculated the mean of PSI values from the samples of the same tissues. To extract muscles/heart and neural-specific exons and to ensure that we only consider functional events, we applied two filters: namely that the exon PSI value in the relevant tissue is higher than 20 and that the <italic>z</italic> score is higher than 2.</p>
    </sec>
    <sec id="Sec14">
      <title>RNA-Seq analysis</title>
      <p id="Par43">Raw RNA-Seq reads for two types of platelets and multiple sclerosis patients were downloaded from the GEO repository (access numbers: GSE126448 and GSE138614 ). The number of samples and sequencing depth are reported in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S3. RNA-Seq reads were aligned to the reference human genome (hg38) using STAR 2.7 [<xref ref-type="bibr" rid="CR113">113</xref>] in a 2-pass mode and filtered for uniquely mapped reads. Differential AS analysis was performed by MAJIQ [<xref ref-type="bibr" rid="CR56">56</xref>] with default parameters, and with a threshold of P(dPSI &gt; 20%) &gt; 0.95.</p>
    </sec>
    <sec id="Sec15">
      <title>NEASE: The Python package</title>
      <p id="Par44">NEASE’s Python package relies on NumPy [<xref ref-type="bibr" rid="CR114">114</xref>], pandas [<xref ref-type="bibr" rid="CR115">115</xref>], NetworkX [<xref ref-type="bibr" rid="CR116">116</xref>], SciPy [<xref ref-type="bibr" rid="CR117">117</xref>], and Statsmodels [<xref ref-type="bibr" rid="CR118">118</xref>]. The gene-level enrichment is also supported in the NEASE package using the Python implementation of Enrichr [<xref ref-type="bibr" rid="CR109">109</xref>]. To speed up the edge hypergeometric test, the total degree of every pathway in the structural PPI, as well as the overall degree of the network were pre-computed. For visualization, we use the complete PPI (not the structural PPI) and extract connected subnetworks from each pathway as well as spliced genes and their interactions with the extracted modules. The position of nodes is computed using the Fruchterman-Reingold force-directed algorithm implemented in NetworkX [<xref ref-type="bibr" rid="CR119">119</xref>]. The interactive visualization for individual genes and events is implemented with information from the DIGGER database and the Plotly package.</p>
      <p id="Par45">The package provides the option to automatically filter exons that are likely to disturb the open reading frame of the transcript based on the prediction in [<xref ref-type="bibr" rid="CR30">30</xref>]. In the case of multiple AS events affecting the same genes, we consider every event individually and identify all protein features. The standard input of the package is a DataFrame object with the exon coordinates and Ensembl IDs of the genes. The package also supports the output of multiple AS differential detection tools such as rMATs [<xref ref-type="bibr" rid="CR120">120</xref>], Whippet [<xref ref-type="bibr" rid="CR121">121</xref>], and also tools that are event-based such as MAJIQ [<xref ref-type="bibr" rid="CR56">56</xref>] where NEASE only considers annotated exons. NEASE is released as open-source under the GPLv3 license and is available at (<ext-link ext-link-type="uri" xlink:href="https://github.com/louadi/NEASE">https://github.com/louadi/NEASE</ext-link>). Step-by-step tutorials for running NEASE are available at (<ext-link ext-link-type="uri" xlink:href="https://github.com/louadi/NEASE-tutorials">https://github.com/louadi/NEASE-tutorials</ext-link>).</p>
    </sec>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec16">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="13059_2021_2538_MOESM1_ESM.pdf">
            <caption>
              <p><bold>Additional file 1:</bold><bold>Tables S1-S3.</bold><bold>Table S1.</bold> Enrichment of the pathway “Muscle contraction” from Reactome for the exons upregulated in the muscles generated by the NEASE package. <bold>Table S2.</bold> Enrichment of the pathway “Synaptic vesicle cycle” from KEGG for the exons upregulated in the neural tissues generated by the NEASE package. <bold>Table S3.</bold> RNA-Seq samples used in the study. <bold>Figs.</bold>
<bold>S1-S6.</bold>
<bold>Fig. S1.</bold> Node degree distribution of the classic PPI and structurally annotated PPI, the latter contains only interactions with evidence from DDIs and DMIs or residue-level evidence from the co-resolved structure. <bold>Fig S2.</bold> Network Enrichment Analysis using EviNet webtool for exons upregulated in muscles and neural tissues. <bold>Fig. S3.</bold> NEASE visualization highlights the interactions of differentially spliced genes with the DCM pathway. <bold>Fig. S4.</bold> The PSI values of two exon skipping events in the genes TPM1 and DST from the GTEx dataset confirm that both the exons are upregulated in muscles and heart tissues. <bold>Fig. S5.</bold> The PSI values of two exon skipping events in the genes CLTA and CLTB from the GTEx dataset confirm that both the exons are upregulated in neural tissues. <bold>Fig. S6.</bold> Pseudocode of NEASE algorithm.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM2">
          <media xlink:href="13059_2021_2538_MOESM2_ESM.xlsx">
            <caption>
              <p><bold>Additional file 2: </bold><bold>Tables S4-S7.</bold> The analysis of the upregulated exons in muscles. <bold>Table S4:</bold> List of spliced domains. <bold>Table S5:</bold> List of affected edges. <bold>Table S6:</bold> Gene-level enrichment. <bold>Table S7:</bold> NEASE enrichment.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM3">
          <media xlink:href="13059_2021_2538_MOESM3_ESM.xlsx">
            <caption>
              <p><bold>Additional file 3: </bold><bold>Tables S8-S11.</bold> The analysis of the upregulated exons in neural. <bold>Table S8.</bold> List of spliced domains. <bold>Table S9.</bold> List of affected edges. <bold>Table S10.</bold> Gene-level enrichment. <bold>Table S11.</bold> NEASE enrichment.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM4">
          <media xlink:href="13059_2021_2538_MOESM4_ESM.xlsx">
            <caption>
              <p><bold>Additional file 4: </bold><bold>Tables S12-S16.</bold> Differential splicing analysis between reticulated platelets and mature platelets. <bold>Table S12.</bold> List of spliced domains. <bold>Table S13.</bold> List of affected edges. <bold>Table S14.</bold> Gene-level enrichment. <bold>Table S15.</bold> NEASE enrichment. <bold>Table S16.</bold> Enrichment of the pathway “GPCR downstream signal”.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM5">
          <media xlink:href="13059_2021_2538_MOESM5_ESM.xlsx">
            <caption>
              <p><bold>Additional file 5: </bold><bold>Tables S17-S21.</bold> Differential splicing analysis between normal-appearing white matter and acute lesion from multiple sclerosis patients. <bold>Table S17.</bold> List of spliced domains. <bold>Table S18.</bold> List of affected edges. <bold>Table S19.</bold> Gene-level enrichment. <bold>Table S20.</bold> NEASE enrichment. <bold>Table S21.</bold> Enrichment of the pathway “Neurotransmitter receptors and postsynaptic signal transmission”.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM6">
          <media xlink:href="13059_2021_2538_MOESM6_ESM.xlsx">
            <caption>
              <p><bold>Additional file 6: </bold><bold>Tables S22-S24.</bold> Differential splicing analysis between Dilated Cardiomyopathy patients and controls. <bold>Table S22.</bold> List of spliced domains. <bold>Table S23.</bold> List of affected edges. <bold>Table S24.</bold> Gene-level enrichment. <bold>Table S25.</bold> NEASE enrichment. <bold>Table S26.</bold> Enrichment of the pathway “Dilated cardiomyopathy”.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM7">
          <media xlink:href="13059_2021_2538_MOESM7_ESM.xlsx">
            <caption>
              <p><bold>Additional file 7: </bold><bold>Table S27.</bold> The PSI values for VastDB exons in different tissues.</p>
            </caption>
          </media>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="MOESM8">
          <media xlink:href="13059_2021_2538_MOESM8_ESM.docx">
            <caption>
              <p><bold>Additional file 8.</bold> Review history.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
    <fn>
      <p>Markus List and Olga Tsoy are joint last authors.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
    <sec id="FPar1">
      <title>Peer review information</title>
      <p id="Par46">Barbara Cheifet was the primary editor of this article and managed its editorial process and peer review in collaboration with the rest of the editorial team.</p>
    </sec>
    <sec id="FPar2">
      <title>Review history</title>
      <p id="Par47">The review history is available as Additional file <xref rid="MOESM8" ref-type="media">8</xref>.</p>
    </sec>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>ZL, TK, OT, JB, and ML conceived the project. ZL performed the initial experiments, developed the method, and implemented the software. OT and ML supervised the project, provided critical feedback, and helped shape the research. OT prepared the RNA-Seq datasets for the differential splicing analysis. AF, CTL interpreted and discussed the biological insights of the results. MK and DB interpreted and discussed the platelet analysis. MLE and ZI interpreted and discussed the Multiple Sclerosis analysis. ZL wrote the initial draft of the manuscript. All authors contributed to writing the final manuscript and approved the final version.</p>
    <sec id="FPar3">
      <title>Authors’ information</title>
      <p id="Par48">Twitters: @ZakariaLouadi (Zakaria Louadi); @itisalist (Markus List); @janbaumbach (Jan Baumbach); @KacprowskiTim (Tim Kacprowski); @meeklug (Melissa Klug)</p>
    </sec>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept [grant 01ZX1908A (Sys_CARE)]. JB was partially funded by his VILLUM Young Investigator Grant (nr.13154). MLE is grateful for financial support from Lundbeckfonden (no. R347-2020-2454). ZI is grateful for financial support from Scleroseforeningen (no. A29926, A 31829, A33600). Open Access funding enabled and organized by Projekt DEAL.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>RNA sequencing data for reticulated platelets was provided by the authors [<xref ref-type="bibr" rid="CR49">49</xref>] and it is freely available at GEO (access number: GSE126448). Multiple sclerosis Raw sequence was provided by the authors [<xref ref-type="bibr" rid="CR69">69</xref>] and freely available at GEO (access number: GSE138614). Dilated Cardiomyopathy raw data is available in the European Genome-phenome Archive (Dataset ID: EGAS00001002454), in our analysis, we used pre-processed data from the manuscript [<xref ref-type="bibr" rid="CR10">10</xref>]. VastDB dataset for humans (hg19) was downloaded from <ext-link ext-link-type="uri" xlink:href="https://vastdb.crg.eu/wiki/Downloads">https://vastdb.crg.eu/wiki/Downloads</ext-link>. The linear motifs instances and interactions were downloaded from (<ext-link ext-link-type="uri" xlink:href="http://elm.eu.org/">http://elm.eu.org/</ext-link>). The generated joint graphs and the exon mapping databases are available on the DIGGER database website <ext-link ext-link-type="uri" xlink:href="https://exbio.wzw.tum.de/digger/download">https://exbio.wzw.tum.de/digger/download</ext-link>. NEASE is released as open-source under the GPLv3 license and is available at GitHub [<xref ref-type="bibr" rid="CR122">122</xref>] and deposited to Zenodo [<xref ref-type="bibr" rid="CR123">123</xref>]. All processed datasets, as well as step-by-step tutorials for using NEASE to reproduce the results presented in this paper, are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/louadi/NEASE-tutorials">https://github.com/louadi/NEASE-tutorials</ext-link> and deposited to Zenodo [<xref ref-type="bibr" rid="CR124">124</xref>].</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar4">
      <title>Ethics approval and consent to participate</title>
      <p id="Par49">Not applicable</p>
    </notes>
    <notes id="FPar5">
      <title>Consent for publication</title>
      <p id="Par50">Not applicable</p>
    </notes>
    <notes id="FPar6" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par51">The authors declare that they have no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Stamm</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ben-Ari</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rafalska</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Toiber</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Thanaraj</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Soreq</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Function of alternative splicing</article-title>
        <source>Gene</source>
        <year>2005</year>
        <volume>344</volume>
        <fpage>1</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1016/j.gene.2004.10.022</pub-id>
        <?supplied-pmid 15656968?>
        <pub-id pub-id-type="pmid">15656968</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yeo</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Holste</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kreiman</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Burge</surname>
            <given-names>CB</given-names>
          </name>
        </person-group>
        <article-title>Variation in alternative splicing across human tissues</article-title>
        <source>Genome Biol</source>
        <year>2004</year>
        <volume>5</volume>
        <issue>10</issue>
        <fpage>R74</fpage>
        <pub-id pub-id-type="doi">10.1186/gb-2004-5-10-r74</pub-id>
        <?supplied-pmid 15461793?>
        <pub-id pub-id-type="pmid">15461793</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <mixed-citation publication-type="other">Baralle F, Giudice J. Alternative splicing as a regulator of development and tissue identity. Nat Rev Mol Cell Biol. 2017;18(7) Available from:. 10.1038/nrm.2017.27.</mixed-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Beqqali</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Alternative splicing in cardiomyopathy</article-title>
        <source>Biophys Rev</source>
        <year>2018</year>
        <volume>10</volume>
        <issue>4</issue>
        <fpage>1061</fpage>
        <lpage>1071</lpage>
        <pub-id pub-id-type="doi">10.1007/s12551-018-0439-y</pub-id>
        <pub-id pub-id-type="pmid">30051286</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Douglas</surname>
            <given-names>AGL</given-names>
          </name>
          <name>
            <surname>Wood</surname>
            <given-names>MJA</given-names>
          </name>
        </person-group>
        <article-title>Splicing therapy for neuromuscular disease</article-title>
        <source>Mol Cell Neurosci</source>
        <year>2013</year>
        <volume>56</volume>
        <fpage>169</fpage>
        <lpage>185</lpage>
        <pub-id pub-id-type="doi">10.1016/j.mcn.2013.04.005</pub-id>
        <?supplied-pmid 23631896?>
        <pub-id pub-id-type="pmid">23631896</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <mixed-citation publication-type="other">​​Evsyukova I, Somarelli JA, Gregory SG, Garcia-Blanco MA. Alternative splicing in multiple sclerosis and other 673 autoimmune diseases. RNA Biology. 2010;7(4)462–73. 10.4161/rna.7.4.12301.</mixed-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>López-Bigas</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Audit</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ouzounis</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Parra</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Guigó</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Are splicing mutations the most frequent cause of hereditary disease?</article-title>
        <source>FEBS Lett</source>
        <year>2005</year>
        <volume>579</volume>
        <issue>9</issue>
        <fpage>1900</fpage>
        <lpage>1903</lpage>
        <pub-id pub-id-type="doi">10.1016/j.febslet.2005.02.047</pub-id>
        <?supplied-pmid 15792793?>
        <pub-id pub-id-type="pmid">15792793</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <mixed-citation publication-type="other">Karlebach G, Veiga DFT, Mays AD, Chatzipantsiou C, Barja PP, Chatzou M, et al. The impact of biological sex on alternative splicing. bioRxiv. 2020:490904. 10.1101/490904.</mixed-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tollervey</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Hortobágyi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Witten</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Zarnack</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kayikci</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Analysis of alternative splicing associated with aging and neurodegeneration in the human brain</article-title>
        <source>Genome Res</source>
        <year>2011</year>
        <volume>21</volume>
        <issue>10</issue>
        <fpage>1572</fpage>
        <lpage>1582</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.122226.111</pub-id>
        <?supplied-pmid 21846794?>
        <pub-id pub-id-type="pmid">21846794</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Heinig</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Adriaens</surname>
            <given-names>ME</given-names>
          </name>
          <name>
            <surname>Schafer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>van Deutekom</surname>
            <given-names>HWM</given-names>
          </name>
          <name>
            <surname>Lodder</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Ware</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Felkin</surname>
            <given-names>LE</given-names>
          </name>
          <name>
            <surname>Creemers</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Meder</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Katus</surname>
            <given-names>HA</given-names>
          </name>
          <name>
            <surname>Rühle</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Stoll</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cambien</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Villard</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Charron</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Varro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bishopric</surname>
            <given-names>NH</given-names>
          </name>
          <name>
            <surname>George</surname>
            <given-names>AL</given-names>
            <suffix>Jr</suffix>
          </name>
          <name>
            <surname>dos Remedios</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Moreno-Moral</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pesce</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bauerfeind</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rüschendorf</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Rintisch</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Petretto</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Barton</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Cook</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Pinto</surname>
            <given-names>YM</given-names>
          </name>
          <name>
            <surname>Bezzina</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Hubner</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Natural genetic variation of the cardiac transcriptome in non-diseased donors and patients with dilated cardiomyopathy</article-title>
        <source>Genome Biol</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>170</fpage>
        <pub-id pub-id-type="doi">10.1186/s13059-017-1286-z</pub-id>
        <?supplied-pmid 28903782?>
        <pub-id pub-id-type="pmid">28903782</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tress</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Abascal</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Valencia</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Alternative Splicing May Not Be the Key to Proteome Complexity</article-title>
        <source>Trends Biochem Sci. Elsevier Ltd</source>
        <year>2017</year>
        <volume>42</volume>
        <issue>2</issue>
        <fpage>98</fpage>
        <lpage>110</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tibs.2016.08.008</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Melamud</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Moult</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Stochastic noise in splicing machinery</article-title>
        <source>Nucleic Acids Res</source>
        <year>2009</year>
        <volume>37</volume>
        <issue>14</issue>
        <fpage>4873</fpage>
        <lpage>4886</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkp471</pub-id>
        <?supplied-pmid 19546110?>
        <pub-id pub-id-type="pmid">19546110</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Coulombe-Huntington</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sheynkman</surname>
            <given-names>GM</given-names>
          </name>
          <name>
            <surname>Hao</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Richardson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Murray</surname>
            <given-names>RR</given-names>
          </name>
          <name>
            <surname>Spirohn</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Begg</surname>
            <given-names>BE</given-names>
          </name>
          <name>
            <surname>Duran-Frigola</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>MacWilliams</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pevzner</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Zhong</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Trigg</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Tam</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ghamsari</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sahni</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Yi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rodriguez</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Balcha</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Costanzo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Andrews</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Boone</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>XJ</given-names>
          </name>
          <name>
            <surname>Salehi-Ashtiani</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Charloteaux</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Calderwood</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Aloy</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Hill</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Iakoucheva</surname>
            <given-names>LM</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Vidal</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing</article-title>
        <source>Cell</source>
        <year>2016</year>
        <volume>164</volume>
        <issue>4</issue>
        <fpage>805</fpage>
        <lpage>817</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2016.01.029</pub-id>
        <?supplied-pmid 26871637?>
        <pub-id pub-id-type="pmid">26871637</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Buljan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chalancon</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Eustermann</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wagner</surname>
            <given-names>GP</given-names>
          </name>
          <name>
            <surname>Fuxreiter</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks</article-title>
        <source>Mol Cell</source>
        <year>2012</year>
        <volume>46</volume>
        <issue>6</issue>
        <fpage>871</fpage>
        <lpage>883</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2012.05.039</pub-id>
        <pub-id pub-id-type="pmid">22749400</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>da Costa</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Menezes</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Romão</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease</article-title>
        <source>Int J Biochem Cell Biol</source>
        <year>2017</year>
        <volume>91</volume>
        <issue>Pt B</issue>
        <fpage>168</fpage>
        <lpage>175</lpage>
        <pub-id pub-id-type="doi">10.1016/j.biocel.2017.07.013</pub-id>
        <pub-id pub-id-type="pmid">28743674</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="book">
        <person-group person-group-type="author">
          <name>
            <surname>Kristoffer</surname>
            <given-names>V-S</given-names>
          </name>
        </person-group>
        <source>Sandelin A</source>
        <year>2017</year>
        <publisher-loc>Genomics</publisher-loc>
        <publisher-name>The Landscape of Isoform Switches in Human Cancers</publisher-name>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <mixed-citation publication-type="other">delafuente L, Arzalluz-luque Á, Tardáguila M, Delrisco H, Martí C, Tarazona S, et al. tappAS: a comprehensive computational framework for the analysis of the functional impact of differential splicing. Genome Biol. 2020;21(1) Available from:. 10.1186/s13059-020-02028-w.</mixed-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gal-Oz</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Haiat</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Eliyahu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Shani</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Shay</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>DoChaP: the domain change presenter</article-title>
        <source>Nucleic Acids Res</source>
        <year>2021</year>
        <volume>49</volume>
        <issue>W1</issue>
        <fpage>W162</fpage>
        <lpage>W168</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkab357</pub-id>
        <?supplied-pmid 33988713?>
        <pub-id pub-id-type="pmid">33988713</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ctor Climente-Gonzá Lez</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Porta-Pardo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Godzik</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Correspondence</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>Eyras</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>The Functional Impact of Alternative Splicing in Cancer</article-title>
        <source>Cell Rep</source>
        <year>2017</year>
        <volume>20</volume>
        <fpage>2215</fpage>
        <lpage>2226</lpage>
        <pub-id pub-id-type="doi">10.1016/j.celrep.2017.08.012</pub-id>
        <pub-id pub-id-type="pmid">28854369</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tranchevent</surname>
            <given-names>L-C</given-names>
          </name>
          <name>
            <surname>Aubé</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dulaurier</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Benoit-Pilven</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rey</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Poret</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification of protein features encoded by alternative exons using Exon Ontology</article-title>
        <source>Genome Res</source>
        <year>2017</year>
        <volume>27</volume>
        <issue>6</issue>
        <fpage>1087</fpage>
        <lpage>1097</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.212696.116</pub-id>
        <pub-id pub-id-type="pmid">28420690</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <mixed-citation publication-type="other"> Louadi Z, Yuan K, Gress A, Tsoy O, Kalinina OV, Baumbach J, et al. DIGGER: exploring the functional role of alternative 709 splicing in protein interactions. Nucleic Acids Res. 2020;49(D1):D309-D318. 10.1093/nar/gkaa768.</mixed-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <mixed-citation publication-type="other">Kumar M, Gouw M, Michael S. Amano-S ´ Anchez HS´, Pancsa R, Glavina J, et al. ELM-the eukaryotic linear motif resource in 2020. Nucleic Acids Res. 2020;48. Available from: <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/nar/article/48/D1/D296/5611669">https://academic.oup.com/nar/article/48/D1/D296/5611669</ext-link>. 10.1093/nar/gkz1030.</mixed-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>El-Gebali</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mistry</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bateman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Eddy</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Luciani</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Potter</surname>
            <given-names>SC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The Pfam protein families database in 2019</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D427</fpage>
        <lpage>D432</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky995</pub-id>
        <?supplied-pmid 30357350?>
        <pub-id pub-id-type="pmid">30357350</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oughtred</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Stark</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Breitkreutz</surname>
            <given-names>B-J</given-names>
          </name>
          <name>
            <surname>Rust</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Boucher</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Kolas</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>O’Donnell</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Leung</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>McAdam</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Dolma</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Willems</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Coulombe-Huntington</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chatr-aryamontri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Dolinski</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Tyers</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The BioGRID interaction database: 2019 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D529</fpage>
        <lpage>D541</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1079</pub-id>
        <?supplied-pmid 30476227?>
        <pub-id pub-id-type="pmid">30476227</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yellaboina</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tasneem</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zaykin</surname>
            <given-names>DV</given-names>
          </name>
          <name>
            <surname>Raghavachari</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Jothi</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>DOMINE: a comprehensive collection of known and predicted domain-domain interactions</article-title>
        <source>Nucleic Acids Res</source>
        <year>2011</year>
        <volume>39</volume>
        <issue>Database issue</issue>
        <fpage>D730</fpage>
        <lpage>D735</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkq1229</pub-id>
        <?supplied-pmid 21113022?>
        <pub-id pub-id-type="pmid">21113022</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mosca</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Céol</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Stein</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Olivella</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Aloy</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>3did: a catalog of domain-based interactions of known three-dimensional structure</article-title>
        <source>Nucleic Acids Res</source>
        <year>2014</year>
        <volume>42</volume>
        <issue>Database issue</issue>
        <fpage>D374</fpage>
        <lpage>D379</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkt887</pub-id>
        <?supplied-pmid 24081580?>
        <pub-id pub-id-type="pmid">24081580</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Westbrook</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gilliland</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>TN</given-names>
          </name>
          <name>
            <surname>Weissig</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shindyalov</surname>
            <given-names>IN</given-names>
          </name>
          <name>
            <surname>Bourne</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>The Protein Data Bank</article-title>
        <source>Nucleic Acids Res</source>
        <year>2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>235</fpage>
        <lpage>242</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id>
        <?supplied-pmid 10592235?>
        <pub-id pub-id-type="pmid">10592235</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kamburov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Stelzl</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Lehrach</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Herwig</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The ConsensusPathDB interaction database: 2013 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>41</volume>
        <issue>Database issue</issue>
        <fpage>D793</fpage>
        <lpage>D800</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1055</pub-id>
        <pub-id pub-id-type="pmid">23143270</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ellis</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Barrios-Rodiles</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Çolak</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Irimia</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Calarco</surname>
            <given-names>JA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tissue-Specific Alternative Splicing Remodels Protein-Protein Interaction Networks</article-title>
        <source>Mol Cell</source>
        <year>2012</year>
        <volume>46</volume>
        <issue>6</issue>
        <fpage>884</fpage>
        <lpage>892</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2012.05.037</pub-id>
        <pub-id pub-id-type="pmid">22749401</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tapial</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ha</surname>
            <given-names>KCH</given-names>
          </name>
          <name>
            <surname>Sterne-Weiler</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gohr</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Braunschweig</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Hermoso-Pulido</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms</article-title>
        <source>Genome Res</source>
        <year>2017</year>
        <volume>27</volume>
        <issue>10</issue>
        <fpage>1759</fpage>
        <lpage>1768</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.220962.117</pub-id>
        <pub-id pub-id-type="pmid">28855263</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Seo</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Ryu</surname>
            <given-names>J-Y</given-names>
          </name>
          <name>
            <surname>Jeong</surname>
            <given-names>E-Y</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>C-M</given-names>
          </name>
        </person-group>
        <article-title>Two splice variants of the IDD14 transcription factor competitively form nonfunctional heterodimers which may regulate starch metabolism</article-title>
        <source>Nat Commun</source>
        <year>2011</year>
        <volume>2</volume>
        <issue>1</issue>
        <fpage>303</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms1303</pub-id>
        <?supplied-pmid 21556057?>
        <pub-id pub-id-type="pmid">21556057</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Alexeyenko</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Pernemalm</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Guegan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Dessen</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lazar</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Lehtiö</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Pawitan</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Network enrichment analysis: extension of gene-set enrichment analysis to gene networks</article-title>
        <source>BMC Bioinformatics</source>
        <year>2012</year>
        <volume>13</volume>
        <issue>1</issue>
        <fpage>226</fpage>
        <pub-id pub-id-type="doi">10.1186/1471-2105-13-226</pub-id>
        <?supplied-pmid 22966941?>
        <pub-id pub-id-type="pmid">22966941</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tansey</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Luby-Phelps</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kamm</surname>
            <given-names>KE</given-names>
          </name>
          <name>
            <surname>Stull</surname>
            <given-names>JT</given-names>
          </name>
        </person-group>
        <article-title>Ca(2+)-dependent phosphorylation of myosin light chain kinase decreases the Ca2+ sensitivity of light chain phosphorylation within smooth muscle cells</article-title>
        <source>J Biol Chem</source>
        <year>1994</year>
        <volume>269</volume>
        <issue>13</issue>
        <fpage>9912</fpage>
        <lpage>9920</lpage>
        <pub-id pub-id-type="doi">10.1016/S0021-9258(17)36969-7</pub-id>
        <pub-id pub-id-type="pmid">8144585</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hall</surname>
            <given-names>CN</given-names>
          </name>
          <name>
            <surname>Klein-Flügge</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Howarth</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Attwell</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Oxidative phosphorylation, not glycolysis, powers presynaptic and postsynaptic mechanisms underlying brain information processing</article-title>
        <source>J Neurosci</source>
        <year>2012</year>
        <volume>32</volume>
        <issue>26</issue>
        <fpage>8940</fpage>
        <lpage>8951</lpage>
        <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0026-12.2012</pub-id>
        <?supplied-pmid 22745494?>
        <pub-id pub-id-type="pmid">22745494</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sanganahalli</surname>
            <given-names>BG</given-names>
          </name>
          <name>
            <surname>Herman</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Blumenfeld</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hyder</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Oxidative neuroenergetics in event-related paradigms</article-title>
        <source>J Neurosci</source>
        <year>2009</year>
        <volume>29</volume>
        <issue>6</issue>
        <fpage>1707</fpage>
        <lpage>1718</lpage>
        <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5549-08.2009</pub-id>
        <?supplied-pmid 19211878?>
        <pub-id pub-id-type="pmid">19211878</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vergara</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Jaramillo-Riveri</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Luarte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Moënne-Loccoz</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fuentes</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Couve</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Maldonado</surname>
            <given-names>PE</given-names>
          </name>
        </person-group>
        <article-title>The Energy Homeostasis Principle: Neuronal Energy Regulation Drives Local Network Dynamics Generating Behavior</article-title>
        <source>Front Comput Neurosci</source>
        <year>2019</year>
        <volume>13</volume>
        <fpage>49</fpage>
        <pub-id pub-id-type="doi">10.3389/fncom.2019.00049</pub-id>
        <?supplied-pmid 31396067?>
        <pub-id pub-id-type="pmid">31396067</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Du</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>X-H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Friedman</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Ugurbil</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Tightly coupled brain activity and cerebral ATP metabolic rate</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2008</year>
        <volume>105</volume>
        <issue>17</issue>
        <fpage>6409</fpage>
        <lpage>6414</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.0710766105</pub-id>
        <?supplied-pmid 18443293?>
        <pub-id pub-id-type="pmid">18443293</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Howarth</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gleeson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Attwell</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Updated energy budgets for neural computation in the neocortex and cerebellum</article-title>
        <source>J Cereb Blood Flow Metab</source>
        <year>2012</year>
        <volume>32</volume>
        <issue>7</issue>
        <fpage>1222</fpage>
        <lpage>1232</lpage>
        <pub-id pub-id-type="doi">10.1038/jcbfm.2012.35</pub-id>
        <?supplied-pmid 22434069?>
        <pub-id pub-id-type="pmid">22434069</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Magistretti</surname>
            <given-names>PJ</given-names>
          </name>
          <name>
            <surname>Allaman</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>A cellular perspective on brain energy metabolism and functional imaging</article-title>
        <source>Neuron</source>
        <year>2015</year>
        <volume>86</volume>
        <issue>4</issue>
        <fpage>883</fpage>
        <lpage>901</lpage>
        <pub-id pub-id-type="doi">10.1016/j.neuron.2015.03.035</pub-id>
        <?supplied-pmid 25996133?>
        <pub-id pub-id-type="pmid">25996133</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Boyer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mertens</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation</article-title>
        <source>Elife</source>
        <year>2016</year>
        <volume>10</volume>
        <fpage>5</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.13374</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hiesinger</surname>
            <given-names>PR</given-names>
          </name>
          <name>
            <surname>Fayyazuddin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mehta</surname>
            <given-names>SQ</given-names>
          </name>
          <name>
            <surname>Rosenmund</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Schulze</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Zhai</surname>
            <given-names>RG</given-names>
          </name>
          <name>
            <surname>Verstreken</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kunz</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bellen</surname>
            <given-names>HJ</given-names>
          </name>
        </person-group>
        <article-title>The v-ATPase V0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila</article-title>
        <source>Cell</source>
        <year>2005</year>
        <volume>121</volume>
        <issue>4</issue>
        <fpage>607</fpage>
        <lpage>620</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2005.03.012</pub-id>
        <?supplied-pmid 15907473?>
        <pub-id pub-id-type="pmid">15907473</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kato</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Akita</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Nakashima</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mutoh</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Akasaka</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Tohyama</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nomura</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hoshino</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ago</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tanaka</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Epstein</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Ben-Haim</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Heyman</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Miyazaki</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Belal</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Takabayashi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ohba</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Takata</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mizuguchi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Miyatake</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Miyake</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Fukuda</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Matsumoto</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Saitsu</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>ATP6V0A1 encoding the a1-subunit of the V0 domain of vacuolar H+-ATPases is essential for brain development in humans and mice</article-title>
        <source>Nat Commun</source>
        <year>2021</year>
        <volume>12</volume>
        <issue>1</issue>
        <fpage>2107</fpage>
        <pub-id pub-id-type="doi">10.1038/s41467-021-22389-5</pub-id>
        <?supplied-pmid 33833240?>
        <pub-id pub-id-type="pmid">33833240</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Poëa-Guyon</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Amar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fossier</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Morel</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Alternative splicing controls neuronal expression of v-ATPase subunit a1 and sorting to nerve terminals</article-title>
        <source>J Biol Chem</source>
        <year>2006</year>
        <volume>281</volume>
        <issue>25</issue>
        <fpage>17164</fpage>
        <lpage>17172</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M600927200</pub-id>
        <?supplied-pmid 16621796?>
        <pub-id pub-id-type="pmid">16621796</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Redlingshöfer</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>McLeod</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Camus</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Burden</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Palomer</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Clathrin light chain diversity regulates membrane deformation in vitro and synaptic vesicle formation in vivo</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2020</year>
        <volume>117</volume>
        <issue>38</issue>
        <fpage>23527</fpage>
        <lpage>23538</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.2003662117</pub-id>
        <pub-id pub-id-type="pmid">32907943</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lonsdale</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Thomas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Salvatore</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Phillips</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Shad</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hasz</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Walters</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Garcia</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Foster</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Moser</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Karasik</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gillard</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ramsey</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sullivan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bridge</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Magazine</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Syron</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fleming</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Siminoff</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Traino</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Mosavel</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Barker</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Jewell</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rohrer</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Maxim</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Filkins</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Harbach</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cortadillo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Berghuis</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Turner</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hudson</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Feenstra</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sobin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Robb</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Branton</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Korzeniewski</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Shive</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Tabor</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Qi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Groch</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nampally</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Buia</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zimmerman</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Burges</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Robinson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Valentino</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bradbury</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Cosentino</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Diaz-Mayoral</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Kennedy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Engel</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Williams</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Erickson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ardlie</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Winckler</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Getz</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>DeLuca</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>MacArthur</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kellis</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gelfand</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Donovan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Meng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Grant</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Mash</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Marcus</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Basile</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Cox</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Nicolae</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Gamazon</surname>
            <given-names>ER</given-names>
          </name>
          <name>
            <surname>Im</surname>
            <given-names>HK</given-names>
          </name>
          <name>
            <surname>Konkashbaev</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Pritchard</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Stevens</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Flutre</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Dermitzakis</surname>
            <given-names>ET</given-names>
          </name>
          <name>
            <surname>Lappalainen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Guigo</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Monlong</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sammeth</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Koller</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Battle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mostafavi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>McCarthy</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rivas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Maller</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rusyn</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Nobel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Wright</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Shabalin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Feolo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sharopova</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Sturcke</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Paschal</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Anderson</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Wilder</surname>
            <given-names>EL</given-names>
          </name>
          <name>
            <surname>Derr</surname>
            <given-names>LK</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>ED</given-names>
          </name>
          <name>
            <surname>Struewing</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Temple</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Volpi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Boyer</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Thomson</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Guyer</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Ng</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Abdallah</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Colantuoni</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Insel</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Koester</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Little</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Bender</surname>
            <given-names>PK</given-names>
          </name>
          <name>
            <surname>Lehner</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Compton</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Vaught</surname>
            <given-names>JB</given-names>
          </name>
          <name>
            <surname>Sawyer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lockhart</surname>
            <given-names>NC</given-names>
          </name>
          <name>
            <surname>Demchok</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>HF</given-names>
          </name>
        </person-group>
        <article-title>The Genotype-Tissue Expression (GTEx) project</article-title>
        <source>Nat Genet</source>
        <year>2013</year>
        <volume>45</volume>
        <issue>6</issue>
        <fpage>580</fpage>
        <lpage>585</lpage>
        <pub-id pub-id-type="doi">10.1038/ng.2653</pub-id>
        <pub-id pub-id-type="pmid">23715323</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rodriguez</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Pozo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>di Domenico</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Vazquez</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tress</surname>
            <given-names>ML</given-names>
          </name>
        </person-group>
        <article-title>An analysis of tissue-specific alternative splicing at the protein level. Orengo CA, editor</article-title>
        <source>PLoS Comput Biol</source>
        <year>2020</year>
        <volume>16</volume>
        <issue>10</issue>
        <fpage>e1008287</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1008287</pub-id>
        <pub-id pub-id-type="pmid">33017396</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Raj</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Blencowe</surname>
            <given-names>BJ</given-names>
          </name>
        </person-group>
        <article-title>Alternative Splicing in the Mammalian Nervous System: Recent Insights into Mechanisms and Functional Roles</article-title>
        <source>Neuron</source>
        <year>2015</year>
        <volume>87</volume>
        <issue>1</issue>
        <fpage>14</fpage>
        <lpage>27</lpage>
        <pub-id pub-id-type="doi">10.1016/j.neuron.2015.05.004</pub-id>
        <?supplied-pmid 26139367?>
        <pub-id pub-id-type="pmid">26139367</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Su</surname>
            <given-names>C-H</given-names>
          </name>
          <name>
            <surname>Dhananjaya</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tarn</surname>
            <given-names>W-Y</given-names>
          </name>
        </person-group>
        <article-title>Alternative Splicing in Neurogenesis and Brain Development</article-title>
        <source>Front Mol Biosci</source>
        <year>2018</year>
        <volume>5</volume>
        <fpage>12</fpage>
        <pub-id pub-id-type="doi">10.3389/fmolb.2018.00012</pub-id>
        <pub-id pub-id-type="pmid">29484299</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bongiovanni</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Santamaria</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Klug</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Santovito</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Felicetta</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hristov</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>von Scheidt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aslani</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Cibella</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Weber</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Moretti</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Laugwitz</surname>
            <given-names>KL</given-names>
          </name>
          <name>
            <surname>Peano</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bernlochner</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Transcriptome Analysis of Reticulated Platelets Reveals a Prothrombotic Profile</article-title>
        <source>Thromb Haemost</source>
        <year>2019</year>
        <volume>119</volume>
        <issue>11</issue>
        <fpage>1795</fpage>
        <lpage>1806</lpage>
        <pub-id pub-id-type="doi">10.1055/s-0039-1695009</pub-id>
        <?supplied-pmid 31473989?>
        <pub-id pub-id-type="pmid">31473989</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ault</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Knowles</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation</article-title>
        <source>Exp Hematol</source>
        <year>1995</year>
        <volume>23</volume>
        <issue>9</issue>
        <fpage>996</fpage>
        <lpage>1001</lpage>
        <?supplied-pmid 7635185?>
        <pub-id pub-id-type="pmid">7635185</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karpatkin</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets</article-title>
        <source>J Clin Invest</source>
        <year>1969</year>
        <volume>48</volume>
        <issue>6</issue>
        <fpage>1083</fpage>
        <lpage>1087</lpage>
        <pub-id pub-id-type="doi">10.1172/JCI106064</pub-id>
        <pub-id pub-id-type="pmid">5771189</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cesari</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Marcucci</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Gori</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Caporale</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Fanelli</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Casola</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Balzi</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Barchielli</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Valente</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Giglioli</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gensini</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Abbate</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Reticulated platelets predict cardiovascular death in acute coronary syndrome patients</article-title>
        <source>Thromb Haemost</source>
        <year>2013</year>
        <volume>109</volume>
        <issue>05</issue>
        <fpage>846</fpage>
        <lpage>853</lpage>
        <pub-id pub-id-type="doi">10.1160/TH12-09-0709</pub-id>
        <?supplied-pmid 23494003?>
        <pub-id pub-id-type="pmid">23494003</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Guthikonda</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Alviar</surname>
            <given-names>CL</given-names>
          </name>
          <name>
            <surname>Vaduganathan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Arikan</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tellez</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>DeLao</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Granada</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>Kleiman</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Lev</surname>
            <given-names>EI</given-names>
          </name>
        </person-group>
        <article-title>Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease</article-title>
        <source>J Am Coll Cardiol</source>
        <year>2008</year>
        <volume>52</volume>
        <issue>9</issue>
        <fpage>743</fpage>
        <lpage>749</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jacc.2008.05.031</pub-id>
        <?supplied-pmid 18718422?>
        <pub-id pub-id-type="pmid">18718422</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Muronoi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Koyama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nunomiya</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lefor</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Wada</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Koinuma</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Shima</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Suzukawa</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Immature platelet fraction predicts coagulopathy-related platelet consumption and mortality in patients with sepsis</article-title>
        <source>Thromb Res</source>
        <year>2016</year>
        <volume>144</volume>
        <fpage>169</fpage>
        <lpage>175</lpage>
        <pub-id pub-id-type="doi">10.1016/j.thromres.2016.06.002</pub-id>
        <?supplied-pmid 27380496?>
        <pub-id pub-id-type="pmid">27380496</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nassa</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Giurato</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Cimmino</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Rizzo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ravo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Salvati</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nyman</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Vesterlund</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lehtiö</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Golino</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Weisz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tarallo</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications</article-title>
        <source>Sci Rep</source>
        <year>2018</year>
        <volume>8</volume>
        <issue>1</issue>
        <fpage>498</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-017-18985-5</pub-id>
        <?supplied-pmid 29323256?>
        <pub-id pub-id-type="pmid">29323256</pub-id>
      </element-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vaquero-Garcia</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Barrera</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Gazzara</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>González-Vallinas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Lahens</surname>
            <given-names>NF</given-names>
          </name>
          <name>
            <surname>Hogenesch</surname>
            <given-names>JB</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A new view of transcriptome complexity and regulation through the lens of local splicing variations</article-title>
        <source>Elife</source>
        <year>2016</year>
        <volume>5</volume>
        <fpage>e11752</fpage>
        <pub-id pub-id-type="doi">10.7554/eLife.11752</pub-id>
        <pub-id pub-id-type="pmid">26829591</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fabregat</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jupe</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sidiropoulos</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Gillespie</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Garapati</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Haw</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Jassal</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Korninger</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>May</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Milacic</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Roca</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Rothfels</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sevilla</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Shamovsky</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Shorser</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Varusai</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Viteri</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Weiser</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Stein</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hermjakob</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>D’Eustachio</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>The Reactome Pathway Knowledgebase</article-title>
        <source>Nucleic Acids Res</source>
        <year>2018</year>
        <volume>46</volume>
        <issue>D1</issue>
        <fpage>D649</fpage>
        <lpage>D655</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkx1132</pub-id>
        <?supplied-pmid 29145629?>
        <pub-id pub-id-type="pmid">29145629</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Scheer</surname>
            <given-names>FAJL</given-names>
          </name>
          <name>
            <surname>Michelson</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Frelinger</surname>
            <given-names>AL</given-names>
            <suffix>3rd</suffix>
          </name>
          <name>
            <surname>Evoniuk</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kelly</surname>
            <given-names>EE</given-names>
          </name>
          <name>
            <surname>McCarthy</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The human endogenous circadian system causes greatest platelet activation during the biological morning independent of behaviors</article-title>
        <source>PLoS One</source>
        <year>2011</year>
        <volume>6</volume>
        <issue>9</issue>
        <fpage>e24549</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0024549</pub-id>
        <pub-id pub-id-type="pmid">21931750</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Offermanns</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Activation of Platelet Function Through G Protein–Coupled Receptors</article-title>
        <source>Circ Res</source>
        <year>2006</year>
        <volume>99</volume>
        <issue>12</issue>
        <fpage>1293</fpage>
        <lpage>1304</lpage>
        <pub-id pub-id-type="doi">10.1161/01.RES.0000251742.71301.16</pub-id>
        <?supplied-pmid 17158345?>
        <pub-id pub-id-type="pmid">17158345</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Marti-Solano</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Crilly</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Malinverni</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Munk</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pearce</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Quon</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mackenzie</surname>
            <given-names>AE</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tobin</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Ladds</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Milligan</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Gloriam</surname>
            <given-names>DE</given-names>
          </name>
          <name>
            <surname>Puthenveedu</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Babu</surname>
            <given-names>MM</given-names>
          </name>
        </person-group>
        <article-title>Combinatorial expression of GPCR isoforms affects signalling and drug responses</article-title>
        <source>Nature</source>
        <year>2020</year>
        <volume>587</volume>
        <issue>7835</issue>
        <fpage>650</fpage>
        <lpage>656</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-020-2888-2</pub-id>
        <?supplied-pmid 33149304?>
        <pub-id pub-id-type="pmid">33149304</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jalagadugula</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dhanasekaran</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kunapuli</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>AK</given-names>
          </name>
        </person-group>
        <article-title>Early growth response transcription factor EGR-1 regulates Galphaq gene in megakaryocytic cells</article-title>
        <source>J Thromb Haemost</source>
        <year>2006</year>
        <volume>4</volume>
        <issue>12</issue>
        <fpage>2678</fpage>
        <lpage>2686</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1538-7836.2006.02229.x</pub-id>
        <pub-id pub-id-type="pmid">16995904</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moore</surname>
            <given-names>SF</given-names>
          </name>
          <name>
            <surname>van den Bosch</surname>
            <given-names>MTJ</given-names>
          </name>
          <name>
            <surname>Hunter</surname>
            <given-names>RW</given-names>
          </name>
          <name>
            <surname>Sakamoto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Poole</surname>
            <given-names>AW</given-names>
          </name>
          <name>
            <surname>Hers</surname>
            <given-names>I</given-names>
          </name>
        </person-group>
        <article-title>Dual regulation of glycogen synthase kinase 3 (GSK3)α/β by protein kinase C (PKC)α and Akt promotes thrombin-mediated integrin αIIbβ3 activation and granule secretion in platelets</article-title>
        <source>J Biol Chem</source>
        <year>2013</year>
        <volume>288</volume>
        <issue>6</issue>
        <fpage>3918</fpage>
        <lpage>3928</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M112.429936</pub-id>
        <?supplied-pmid 23239877?>
        <pub-id pub-id-type="pmid">23239877</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Harper</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Poole</surname>
            <given-names>AW</given-names>
          </name>
        </person-group>
        <article-title>Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation</article-title>
        <source>J Thromb Haemost</source>
        <year>2010</year>
        <volume>8</volume>
        <issue>3</issue>
        <fpage>454</fpage>
        <lpage>462</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1538-7836.2009.03722.x</pub-id>
        <?supplied-pmid 20002545?>
        <pub-id pub-id-type="pmid">20002545</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Williams</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Harper</surname>
            <given-names>MT</given-names>
          </name>
          <name>
            <surname>Poole</surname>
            <given-names>AW</given-names>
          </name>
        </person-group>
        <article-title>PKCα negatively regulates in vitro proplatelet formation and in vivo platelet production in mice</article-title>
        <source>Platelets</source>
        <year>2014</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>62</fpage>
        <lpage>68</lpage>
        <pub-id pub-id-type="doi">10.3109/09537104.2012.761686</pub-id>
        <pub-id pub-id-type="pmid">23402219</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ault</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Rinder</surname>
            <given-names>HM</given-names>
          </name>
          <name>
            <surname>Mitchell</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Carmody</surname>
            <given-names>MB</given-names>
          </name>
          <name>
            <surname>Vary</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Hillman</surname>
            <given-names>RS</given-names>
          </name>
        </person-group>
        <article-title>The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis</article-title>
        <source>Am J Clin Pathol</source>
        <year>1992</year>
        <volume>98</volume>
        <issue>6</issue>
        <fpage>637</fpage>
        <lpage>646</lpage>
        <pub-id pub-id-type="doi">10.1093/ajcp/98.6.637</pub-id>
        <?supplied-pmid 1281383?>
        <pub-id pub-id-type="pmid">1281383</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bö</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Dawson</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Wesselingh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Mörk</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Kong</surname>
            <given-names>PA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains</article-title>
        <source>Ann Neurol</source>
        <year>1994</year>
        <volume>36</volume>
        <issue>5</issue>
        <fpage>778</fpage>
        <lpage>786</lpage>
        <pub-id pub-id-type="doi">10.1002/ana.410360515</pub-id>
        <?supplied-pmid 7526776?>
        <pub-id pub-id-type="pmid">7526776</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ludwin</surname>
            <given-names>SK</given-names>
          </name>
        </person-group>
        <article-title>The pathogenesis of multiple sclerosis: relating human pathology to experimental studies</article-title>
        <source>J Neuropathol Exp Neurol</source>
        <year>2006</year>
        <volume>65</volume>
        <issue>4</issue>
        <fpage>305</fpage>
        <lpage>318</lpage>
        <pub-id pub-id-type="doi">10.1097/01.jnen.0000225024.12074.80</pub-id>
        <?supplied-pmid 16691112?>
        <pub-id pub-id-type="pmid">16691112</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hecker</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rüge</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Putscher</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Boxberger</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rommer</surname>
            <given-names>PS</given-names>
          </name>
          <name>
            <surname>Fitzner</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zettl</surname>
            <given-names>UK</given-names>
          </name>
        </person-group>
        <article-title>Aberrant expression of alternative splicing variants in multiple sclerosis - A systematic review</article-title>
        <source>Autoimmun Rev</source>
        <year>2019</year>
        <volume>18</volume>
        <issue>7</issue>
        <fpage>721</fpage>
        <lpage>732</lpage>
        <pub-id pub-id-type="doi">10.1016/j.autrev.2019.05.010</pub-id>
        <?supplied-pmid 31059848?>
        <pub-id pub-id-type="pmid">31059848</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Elkjaer</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Frisch</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Reynolds</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kacprowski</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Burton</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kruse</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Thomassen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Baumbach</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Illes</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis</article-title>
        <source>Acta Neuropathol Commun</source>
        <year>2019</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>205</fpage>
        <pub-id pub-id-type="doi">10.1186/s40478-019-0855-7</pub-id>
        <?supplied-pmid 31829262?>
        <pub-id pub-id-type="pmid">31829262</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gissel</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Ca2+ accumulation and cell damage in skeletal muscle during low frequency stimulation</article-title>
        <source>Eur J Appl Physiol</source>
        <year>2000</year>
        <volume>83</volume>
        <issue>2-3</issue>
        <fpage>175</fpage>
        <lpage>180</lpage>
        <pub-id pub-id-type="doi">10.1007/s004210000276</pub-id>
        <?supplied-pmid 11104058?>
        <pub-id pub-id-type="pmid">11104058</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maléth</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hegyi</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Ca2+ toxicity and mitochondrial damage in acute pancreatitis: translational overview</article-title>
        <source>Philos Trans R Soc Lond B Biol Sci</source>
        <year>2016</year>
        <volume>5</volume>
        <issue>1700</issue>
        <fpage>371(1700)</fpage>
        <pub-id pub-id-type="doi">10.1098/rstb.2015.0425</pub-id>
      </element-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Minagar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Alexander</surname>
            <given-names>JS</given-names>
          </name>
        </person-group>
        <article-title>Blood-brain barrier disruption in multiple sclerosis</article-title>
        <source>Mult Scler</source>
        <year>2003</year>
        <volume>9</volume>
        <issue>6</issue>
        <fpage>540</fpage>
        <lpage>549</lpage>
        <pub-id pub-id-type="doi">10.1191/1352458503ms965oa</pub-id>
        <?supplied-pmid 14664465?>
        <pub-id pub-id-type="pmid">14664465</pub-id>
      </element-citation>
    </ref>
    <ref id="CR73">
      <label>73.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Claudio</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Raine</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Brosnan</surname>
            <given-names>CF</given-names>
          </name>
        </person-group>
        <article-title>Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis</article-title>
        <source>Acta Neuropathol</source>
        <year>1995</year>
        <volume>90</volume>
        <issue>3</issue>
        <fpage>228</fpage>
        <lpage>238</lpage>
        <pub-id pub-id-type="doi">10.1007/BF00296505</pub-id>
        <pub-id pub-id-type="pmid">8525795</pub-id>
      </element-citation>
    </ref>
    <ref id="CR74">
      <label>74.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ortiz</surname>
            <given-names>GG</given-names>
          </name>
          <name>
            <surname>Pacheco-Moisés</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Macías-Islas</surname>
            <given-names>MÁ</given-names>
          </name>
          <name>
            <surname>Flores-Alvarado</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Mireles-Ramírez</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>González-Renovato</surname>
            <given-names>ED</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Role of the blood-brain barrier in multiple sclerosis</article-title>
        <source>Arch Med Res</source>
        <year>2014</year>
        <volume>45</volume>
        <issue>8</issue>
        <fpage>687</fpage>
        <lpage>697</lpage>
        <pub-id pub-id-type="doi">10.1016/j.arcmed.2014.11.013</pub-id>
        <pub-id pub-id-type="pmid">25431839</pub-id>
      </element-citation>
    </ref>
    <ref id="CR75">
      <label>75.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ascherio</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Munger</surname>
            <given-names>KL</given-names>
          </name>
        </person-group>
        <article-title>Environmental risk factors for multiple sclerosis. Part I: the role of infection</article-title>
        <source>Ann Neurol</source>
        <year>2007</year>
        <volume>61</volume>
        <issue>4</issue>
        <fpage>288</fpage>
        <lpage>299</lpage>
        <pub-id pub-id-type="doi">10.1002/ana.21117</pub-id>
        <pub-id pub-id-type="pmid">17444504</pub-id>
      </element-citation>
    </ref>
    <ref id="CR76">
      <label>76.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Baranzini</surname>
            <given-names>SE</given-names>
          </name>
          <name>
            <surname>Srinivasan</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Khankhanian</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Okuda</surname>
            <given-names>DT</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Hauser</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Oksenberg</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Pelletier</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis</article-title>
        <source>Brain</source>
        <year>2010</year>
        <volume>133</volume>
        <issue>9</issue>
        <fpage>2603</fpage>
        <lpage>2611</lpage>
        <pub-id pub-id-type="doi">10.1093/brain/awq192</pub-id>
        <?supplied-pmid 20802204?>
        <pub-id pub-id-type="pmid">20802204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR77">
      <label>77.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Strijbis</surname>
            <given-names>EMM</given-names>
          </name>
          <name>
            <surname>Inkster</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Vounou</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Naegelin</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Kappos</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Radue</surname>
            <given-names>E-W</given-names>
          </name>
          <name>
            <surname>Matthews</surname>
            <given-names>PM</given-names>
          </name>
          <name>
            <surname>Uitdehaag</surname>
            <given-names>BMJ</given-names>
          </name>
          <name>
            <surname>Barkhof</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Polman</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Montana</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Geurts</surname>
            <given-names>JJG</given-names>
          </name>
        </person-group>
        <article-title>Glutamate gene polymorphisms predict brain volumes in multiple sclerosis</article-title>
        <source>Mult Scler</source>
        <year>2013</year>
        <volume>19</volume>
        <issue>3</issue>
        <fpage>281</fpage>
        <lpage>288</lpage>
        <pub-id pub-id-type="doi">10.1177/1352458512454345</pub-id>
        <?supplied-pmid 22851457?>
        <pub-id pub-id-type="pmid">22851457</pub-id>
      </element-citation>
    </ref>
    <ref id="CR78">
      <label>78.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Pappas</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>De Jager</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Pelletier</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>de Bakker</surname>
            <given-names>PI</given-names>
          </name>
          <name>
            <surname>Kappos</surname>
            <given-names>L</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data</article-title>
        <source>Genome Med</source>
        <year>2011</year>
        <volume>3</volume>
        <issue>1</issue>
        <fpage>3</fpage>
        <pub-id pub-id-type="doi">10.1186/gm217</pub-id>
        <?supplied-pmid 21244703?>
        <pub-id pub-id-type="pmid">21244703</pub-id>
      </element-citation>
    </ref>
    <ref id="CR79">
      <label>79.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Keshet</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Seger</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions</article-title>
        <source>Methods Mol Biol</source>
        <year>2010</year>
        <volume>661</volume>
        <fpage>3</fpage>
        <lpage>38</lpage>
        <pub-id pub-id-type="doi">10.1007/978-1-60761-795-2_1</pub-id>
        <?supplied-pmid 20811974?>
        <pub-id pub-id-type="pmid">20811974</pub-id>
      </element-citation>
    </ref>
    <ref id="CR80">
      <label>80.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Karin</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Mammalian MAP kinase signalling cascades</article-title>
        <source>Nature</source>
        <year>2001</year>
        <volume>410</volume>
        <issue>6824</issue>
        <fpage>37</fpage>
        <lpage>40</lpage>
        <pub-id pub-id-type="doi">10.1038/35065000</pub-id>
        <?supplied-pmid 11242034?>
        <pub-id pub-id-type="pmid">11242034</pub-id>
      </element-citation>
    </ref>
    <ref id="CR81">
      <label>81.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shchetynsky</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Protsyuk</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ronninger</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Diaz-Gallo</surname>
            <given-names>L-M</given-names>
          </name>
          <name>
            <surname>Klareskog</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Padyukov</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Gene-gene interaction and RNA splicing profiles of MAP2K4 gene in rheumatoid arthritis</article-title>
        <source>Clin Immunol</source>
        <year>2015</year>
        <volume>158</volume>
        <issue>1</issue>
        <fpage>19</fpage>
        <lpage>28</lpage>
        <pub-id pub-id-type="doi">10.1016/j.clim.2015.02.011</pub-id>
        <pub-id pub-id-type="pmid">25732927</pub-id>
      </element-citation>
    </ref>
    <ref id="CR82">
      <label>82.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tuller</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Atar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ruppin</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Gurevich</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Achiron</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases</article-title>
        <source>Genes Immun</source>
        <year>2013</year>
        <volume>14</volume>
        <issue>2</issue>
        <fpage>67</fpage>
        <lpage>82</lpage>
        <pub-id pub-id-type="doi">10.1038/gene.2012.55</pub-id>
        <pub-id pub-id-type="pmid">23190644</pub-id>
      </element-citation>
    </ref>
    <ref id="CR83">
      <label>83.</label>
      <mixed-citation publication-type="other">GJA t B, Bolk J, `t Hart BA, Laman JD. Multiple sclerosis is linked to MAPKERK overactivity in microglia. J Mol Med. 2021; Available from:. 10.1007/s00109-021-02080-4.</mixed-citation>
    </ref>
    <ref id="CR84">
      <label>84.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mass</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Jacome-Galarza</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Blank</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Lazarov</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Durham</surname>
            <given-names>BH</given-names>
          </name>
          <name>
            <surname>Ozkaya</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pastore</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schwabenland</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chung</surname>
            <given-names>YR</given-names>
          </name>
          <name>
            <surname>Rosenblum</surname>
            <given-names>MK</given-names>
          </name>
          <name>
            <surname>Prinz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Abdel-Wahab</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Geissmann</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease</article-title>
        <source>Nature</source>
        <year>2017</year>
        <volume>549</volume>
        <issue>7672</issue>
        <fpage>389</fpage>
        <lpage>393</lpage>
        <pub-id pub-id-type="doi">10.1038/nature23672</pub-id>
        <?supplied-pmid 28854169?>
        <pub-id pub-id-type="pmid">28854169</pub-id>
      </element-citation>
    </ref>
    <ref id="CR85">
      <label>85.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kotelnikova</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kiani</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Messinis</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Pertsovskaya</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Pliaka</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Bernardo-Faura</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Rinas</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vila</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zubizarreta</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Pulido-Valdeolivas</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Sakellaropoulos</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Faigle</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Silberberg</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Masso</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Stridh</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Behrens</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Olsson</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Paul</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Alexopoulos</surname>
            <given-names>LG</given-names>
          </name>
          <name>
            <surname>Saez-Rodriguez</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tegner</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Villoslada</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2019</year>
        <volume>116</volume>
        <issue>19</issue>
        <fpage>9671</fpage>
        <lpage>9676</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1818347116</pub-id>
        <?supplied-pmid 31004050?>
        <pub-id pub-id-type="pmid">31004050</pub-id>
      </element-citation>
    </ref>
    <ref id="CR86">
      <label>86.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Krementsov</surname>
            <given-names>DN</given-names>
          </name>
          <name>
            <surname>Thornton</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Teuscher</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rincon</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models</article-title>
        <source>Mol Cell Biol</source>
        <year>2013</year>
        <volume>33</volume>
        <issue>19</issue>
        <fpage>3728</fpage>
        <lpage>3734</lpage>
        <pub-id pub-id-type="doi">10.1128/MCB.00688-13</pub-id>
        <pub-id pub-id-type="pmid">23897428</pub-id>
      </element-citation>
    </ref>
    <ref id="CR87">
      <label>87.</label>
      <mixed-citation publication-type="other">Bernardo-Faura M, Rinas M, Wirbel J, Pertsovskaya I, Pliaka V, Messinis DE, Vila G, Sakellaropoulos T, Faigle W, Stridh P, Behrens JR. Prediction of combination therapies based on topological modeling of the immune signaling network in Multiple Sclerosis. Genome Medicine. 2021;13(1):1-6.</mixed-citation>
    </ref>
    <ref id="CR88">
      <label>88.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Maatz</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jens</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Liss</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schafer</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Heinig</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kirchner</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Adami</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Rintisch</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Dauksaite</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Radke</surname>
            <given-names>MH</given-names>
          </name>
          <name>
            <surname>Selbach</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Barton</surname>
            <given-names>PJR</given-names>
          </name>
          <name>
            <surname>Cook</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Rajewsky</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gotthardt</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Landthaler</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hubner</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>RNA-binding protein RBM20 represses splicing to orchestrate cardiac pre-mRNA processing</article-title>
        <source>J Clin Invest</source>
        <year>2014</year>
        <volume>124</volume>
        <issue>8</issue>
        <fpage>3419</fpage>
        <lpage>3430</lpage>
        <pub-id pub-id-type="doi">10.1172/JCI74523</pub-id>
        <?supplied-pmid 24960161?>
        <pub-id pub-id-type="pmid">24960161</pub-id>
      </element-citation>
    </ref>
    <ref id="CR89">
      <label>89.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sheikh</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lyon</surname>
            <given-names>RC</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Functions of myosin light chain-2 (MYL2) in cardiac muscle and disease</article-title>
        <source>Gene</source>
        <year>2015</year>
        <volume>569</volume>
        <issue>1</issue>
        <fpage>14</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1016/j.gene.2015.06.027</pub-id>
        <pub-id pub-id-type="pmid">26074085</pub-id>
      </element-citation>
    </ref>
    <ref id="CR90">
      <label>90.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Matyushenko</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Levitsky</surname>
            <given-names>DI</given-names>
          </name>
        </person-group>
        <article-title>Molecular Mechanisms of Pathologies of Skeletal and Cardiac Muscles Caused by Point Mutations in the Tropomyosin Genes</article-title>
        <source>Biochemistry</source>
        <year>2020</year>
        <volume>85</volume>
        <issue>Suppl 1</issue>
        <fpage>S20</fpage>
        <lpage>S33</lpage>
        <?supplied-pmid 32087052?>
        <pub-id pub-id-type="pmid">32087052</pub-id>
      </element-citation>
    </ref>
    <ref id="CR91">
      <label>91.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Caleshu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Sakhuja</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Nussbaum</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Schiller</surname>
            <given-names>NB</given-names>
          </name>
          <name>
            <surname>Ursell</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Eng</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>de Marco</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>McGlothlin</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Burchard</surname>
            <given-names>EG</given-names>
          </name>
          <name>
            <surname>Rame</surname>
            <given-names>JE</given-names>
          </name>
        </person-group>
        <article-title>Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy</article-title>
        <source>Am J Med Genet A</source>
        <year>2011</year>
        <volume>155A</volume>
        <issue>9</issue>
        <fpage>2229</fpage>
        <lpage>2235</lpage>
        <pub-id pub-id-type="doi">10.1002/ajmg.a.34097</pub-id>
        <?supplied-pmid 21823217?>
        <pub-id pub-id-type="pmid">21823217</pub-id>
      </element-citation>
    </ref>
    <ref id="CR92">
      <label>92.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Brody</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Hacker</surname>
            <given-names>TA</given-names>
          </name>
          <name>
            <surname>Patel</surname>
            <given-names>JR</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sadoshima</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tevosian</surname>
            <given-names>SG</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ablation of the cardiac-specific gene leucine-rich repeat containing 10 (Lrrc10) results in dilated cardiomyopathy</article-title>
        <source>PLoS One</source>
        <year>2012</year>
        <volume>7</volume>
        <issue>12</issue>
        <fpage>e51621</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0051621</pub-id>
        <pub-id pub-id-type="pmid">23236519</pub-id>
      </element-citation>
    </ref>
    <ref id="CR93">
      <label>93.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gupte</surname>
            <given-names>TM</given-names>
          </name>
          <name>
            <surname>Haque</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Gangadharan</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sunitha</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Mukherjee</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Anandhan</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Mechanistic Heterogeneity in Contractile Properties of α-Tropomyosin (TPM1) Mutants Associated with Inherited Cardiomyopathies*</article-title>
        <source>J Biol Chem</source>
        <year>2015</year>
        <volume>290</volume>
        <issue>11</issue>
        <fpage>7003</fpage>
        <lpage>7015</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M114.596676</pub-id>
        <pub-id pub-id-type="pmid">25548289</pub-id>
      </element-citation>
    </ref>
    <ref id="CR94">
      <label>94.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>C-C</given-names>
          </name>
          <name>
            <surname>Kazmierczak</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Morales</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain</article-title>
        <source>FEBS J</source>
        <year>2015</year>
        <volume>282</volume>
        <issue>12</issue>
        <fpage>2379</fpage>
        <lpage>2393</lpage>
        <pub-id pub-id-type="doi">10.1111/febs.13286</pub-id>
        <pub-id pub-id-type="pmid">25825243</pub-id>
      </element-citation>
    </ref>
    <ref id="CR95">
      <label>95.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Herman</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Lam</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Taylor</surname>
            <given-names>MRG</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Teekakirikul</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Christodoulou</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Conner</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>DePalma</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>McDonough</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Sparks</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Teodorescu</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Cirino</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Banner</surname>
            <given-names>NR</given-names>
          </name>
          <name>
            <surname>Pennell</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Graw</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Merlo</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>di Lenarda</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sinagra</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Bos</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Ackerman</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Mitchell</surname>
            <given-names>RN</given-names>
          </name>
          <name>
            <surname>Murry</surname>
            <given-names>CE</given-names>
          </name>
          <name>
            <surname>Lakdawala</surname>
            <given-names>NK</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>CY</given-names>
          </name>
          <name>
            <surname>Barton</surname>
            <given-names>PJR</given-names>
          </name>
          <name>
            <surname>Cook</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>Mestroni</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Seidman</surname>
            <given-names>JG</given-names>
          </name>
          <name>
            <surname>Seidman</surname>
            <given-names>CE</given-names>
          </name>
        </person-group>
        <article-title>Truncations of titin causing dilated cardiomyopathy</article-title>
        <source>N Engl J Med</source>
        <year>2012</year>
        <volume>366</volume>
        <issue>7</issue>
        <fpage>619</fpage>
        <lpage>628</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMoa1110186</pub-id>
        <?supplied-pmid 22335739?>
        <pub-id pub-id-type="pmid">22335739</pub-id>
      </element-citation>
    </ref>
    <ref id="CR96">
      <label>96.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Marston</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Montgiraud</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Munster</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Copeland</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Dos Remedios</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>OBSCN Mutations Associated with Dilated Cardiomyopathy and Haploinsufficiency</article-title>
        <source>PLoS One</source>
        <year>2015</year>
        <volume>10</volume>
        <issue>9</issue>
        <fpage>e0138568</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0138568</pub-id>
        <pub-id pub-id-type="pmid">26406308</pub-id>
      </element-citation>
    </ref>
    <ref id="CR97">
      <label>97.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Marston</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Obscurin variants and inherited cardiomyopathies</article-title>
        <source>Biophys Rev</source>
        <year>2017</year>
        <volume>9</volume>
        <issue>3</issue>
        <fpage>239</fpage>
        <lpage>243</lpage>
        <pub-id pub-id-type="doi">10.1007/s12551-017-0264-8</pub-id>
        <?supplied-pmid 28510120?>
        <pub-id pub-id-type="pmid">28510120</pub-id>
      </element-citation>
    </ref>
    <ref id="CR98">
      <label>98.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>McNally</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Mestroni</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Dilated Cardiomyopathy: Genetic Determinants and Mechanisms</article-title>
        <source>Circ Res</source>
        <year>2017</year>
        <volume>121</volume>
        <issue>7</issue>
        <fpage>731</fpage>
        <lpage>748</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.309396</pub-id>
        <?supplied-pmid 28912180?>
        <pub-id pub-id-type="pmid">28912180</pub-id>
      </element-citation>
    </ref>
    <ref id="CR99">
      <label>99.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Boczek</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Tester</surname>
            <given-names>DJ</given-names>
          </name>
          <name>
            <surname>Huseby</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bos</surname>
            <given-names>JM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death</article-title>
        <source>Circ Arrhythm Electrophysiol</source>
        <year>2015</year>
        <volume>8</volume>
        <issue>5</issue>
        <fpage>1122</fpage>
        <lpage>1132</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCEP.115.002745</pub-id>
        <pub-id pub-id-type="pmid">26253506</pub-id>
      </element-citation>
    </ref>
    <ref id="CR100">
      <label>100.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mouton</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ronjat</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jona</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Villaz</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Feltz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Maulet</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Skeletal and cardiac ryanodine receptors bind to the Ca(2+)-sensor region of dihydropyridine receptor alpha(1C) subunit</article-title>
        <source>FEBS Lett</source>
        <year>2001</year>
        <volume>505</volume>
        <issue>3</issue>
        <fpage>441</fpage>
        <lpage>444</lpage>
        <pub-id pub-id-type="doi">10.1016/S0014-5793(01)02866-6</pub-id>
        <?supplied-pmid 11576544?>
        <pub-id pub-id-type="pmid">11576544</pub-id>
      </element-citation>
    </ref>
    <ref id="CR101">
      <label>101.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kanehisa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>KEGG: kyoto encyclopedia of genes and genomes</article-title>
        <source>Nucleic Acids Res</source>
        <year>2000</year>
        <volume>28</volume>
        <issue>1</issue>
        <fpage>27</fpage>
        <lpage>30</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/28.1.27</pub-id>
        <pub-id pub-id-type="pmid">10592173</pub-id>
      </element-citation>
    </ref>
    <ref id="CR102">
      <label>102.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ather</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Respress</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wehrens</surname>
            <given-names>XHT</given-names>
          </name>
        </person-group>
        <article-title>Alterations in ryanodine receptors and related proteins in heart failure</article-title>
        <source>Biochim Biophys Acta</source>
        <year>2013</year>
        <volume>1832</volume>
        <issue>12</issue>
        <fpage>2425</fpage>
        <lpage>2431</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbadis.2013.06.008</pub-id>
        <?supplied-pmid 23770282?>
        <pub-id pub-id-type="pmid">23770282</pub-id>
      </element-citation>
    </ref>
    <ref id="CR103">
      <label>103.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yano</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Yamamoto</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kobayashi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Matsuzaki</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Role of ryanodine receptor as a Ca2+ regulatory center in normal and failing hearts</article-title>
        <source>J Cardiol</source>
        <year>2009</year>
        <volume>53</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>7</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jjcc.2008.10.008</pub-id>
        <?supplied-pmid 19167631?>
        <pub-id pub-id-type="pmid">19167631</pub-id>
      </element-citation>
    </ref>
    <ref id="CR104">
      <label>104.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Moccia</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lodola</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Stadiotti</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Pilato</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Bellin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Carugo</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pompilio</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sommariva</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Maione</surname>
            <given-names>AS</given-names>
          </name>
        </person-group>
        <article-title>Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration?</article-title>
        <source>Int J Mol Sci</source>
        <year>2019</year>
        <volume>16</volume>
        <issue>16</issue>
        <fpage>20(16)</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms20163986</pub-id>
      </element-citation>
    </ref>
    <ref id="CR105">
      <label>105.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jaffrey</surname>
            <given-names>SR</given-names>
          </name>
          <name>
            <surname>Wilkinson</surname>
            <given-names>MF</given-names>
          </name>
        </person-group>
        <article-title>Nonsense-mediated RNA decay in the brain: emerging modulator of neural development and disease</article-title>
        <source>Nat Rev Neurosci</source>
        <year>2018</year>
        <volume>19</volume>
        <issue>12</issue>
        <fpage>715</fpage>
        <lpage>728</lpage>
        <pub-id pub-id-type="doi">10.1038/s41583-018-0079-z</pub-id>
        <pub-id pub-id-type="pmid">30410025</pub-id>
      </element-citation>
    </ref>
    <ref id="CR106">
      <label>106.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schwerk</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Schulze-Osthoff</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Regulation of apoptosis by alternative pre-mRNA splicing</article-title>
        <source>Mol Cell</source>
        <year>2005</year>
        <volume>19</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>13</lpage>
        <pub-id pub-id-type="doi">10.1016/j.molcel.2005.05.026</pub-id>
        <pub-id pub-id-type="pmid">15989960</pub-id>
      </element-citation>
    </ref>
    <ref id="CR107">
      <label>107.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>List</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Alcaraz</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Dissing-Hansen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ditzel</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Mollenhauer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Baumbach</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>KeyPathwayMinerWeb: online multi-omics network enrichment</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <issue>W1</issue>
        <fpage>W98</fpage>
        <lpage>104</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw373</pub-id>
        <pub-id pub-id-type="pmid">27150809</pub-id>
      </element-citation>
    </ref>
    <ref id="CR108">
      <label>108.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kinsella</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Kähäri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Haider</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zamora</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Proctor</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Spudich</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Ensembl BioMarts: a hub for data retrieval across taxonomic space</article-title>
        <source>Database</source>
        <year>2011</year>
        <volume>2011</volume>
        <fpage>bar030</fpage>
        <pub-id pub-id-type="doi">10.1093/database/bar030</pub-id>
        <pub-id pub-id-type="pmid">21785142</pub-id>
      </element-citation>
    </ref>
    <ref id="CR109">
      <label>109.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kuleshov</surname>
            <given-names>MV</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Rouillard</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>NF</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Koplev</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jenkins</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Jagodnik</surname>
            <given-names>KM</given-names>
          </name>
          <name>
            <surname>Lachmann</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>McDermott</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Monteiro</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Gundersen</surname>
            <given-names>GW</given-names>
          </name>
          <name>
            <surname>Ma'ayan</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title>
        <source>Nucleic Acids Res</source>
        <year>2016</year>
        <volume>44</volume>
        <issue>W1</issue>
        <fpage>W90</fpage>
        <lpage>W97</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id>
        <?supplied-pmid 27141961?>
        <pub-id pub-id-type="pmid">27141961</pub-id>
      </element-citation>
    </ref>
    <ref id="CR110">
      <label>110.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Signorelli</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Vinciotti</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Wit</surname>
            <given-names>EC</given-names>
          </name>
        </person-group>
        <article-title>NEAT: an efficient network enrichment analysis test</article-title>
        <source>BMC Bioinformatics</source>
        <year>2016</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>352</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-016-1203-6</pub-id>
        <?supplied-pmid 27597310?>
        <pub-id pub-id-type="pmid">27597310</pub-id>
      </element-citation>
    </ref>
    <ref id="CR111">
      <label>111.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Benjamini</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hochberg</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing</article-title>
        <source>J Royal Stat Soc: Ser B (Methodological)</source>
        <year>1995</year>
        <volume>57</volume>
        <fpage>289</fpage>
        <lpage>300</lpage>
        <pub-id pub-id-type="doi">10.1111/j.2517-6161.1995.tb02031.x</pub-id>
      </element-citation>
    </ref>
    <ref id="CR112">
      <label>112.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Irimia</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Weatheritt</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Ellis</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Parikshak</surname>
            <given-names>NN</given-names>
          </name>
          <name>
            <surname>Gonatopoulos-Pournatzis</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Babor</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Quesnel-Vallières</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tapial</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Raj</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>O’Hanlon</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Barrios-Rodiles</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sternberg</surname>
            <given-names>MJE</given-names>
          </name>
          <name>
            <surname>Cordes</surname>
            <given-names>SP</given-names>
          </name>
          <name>
            <surname>Roth</surname>
            <given-names>FP</given-names>
          </name>
          <name>
            <surname>Wrana</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Geschwind</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Blencowe</surname>
            <given-names>BJ</given-names>
          </name>
        </person-group>
        <article-title>A highly conserved program of neuronal microexons is misregulated in autistic brains</article-title>
        <source>Cell</source>
        <year>2014</year>
        <volume>159</volume>
        <issue>7</issue>
        <fpage>1511</fpage>
        <lpage>1523</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2014.11.035</pub-id>
        <?supplied-pmid 25525873?>
        <pub-id pub-id-type="pmid">25525873</pub-id>
      </element-citation>
    </ref>
    <ref id="CR113">
      <label>113.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dobin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>CA</given-names>
          </name>
          <name>
            <surname>Schlesinger</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Drenkow</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zaleski</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Jha</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>STAR: ultrafast universal RNA-seq aligner</article-title>
        <source>Bioinformatics</source>
        <year>2013</year>
        <volume>29</volume>
        <issue>1</issue>
        <fpage>15</fpage>
        <lpage>21</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts635</pub-id>
        <pub-id pub-id-type="pmid">23104886</pub-id>
      </element-citation>
    </ref>
    <ref id="CR114">
      <label>114.</label>
      <mixed-citation publication-type="other">Van Der Walt S, Chris Colbert S, Varoquaux G. The NumPy array: a structure for efficient numerical computation. arXiv [cs.MS]. 2011; Available from: <ext-link ext-link-type="uri" xlink:href="http://arxiv.org/abs/1102.1523">http://arxiv.org/abs/1102.1523</ext-link>.</mixed-citation>
    </ref>
    <ref id="CR115">
      <label>115.</label>
      <mixed-citation publication-type="other">McKinney W, Others. Data structures for statistical computing in python. Proceedings of the 9th Python in Science Conference. 2010;445:51–6. 10.25080/Majora-92bf1922-00a.</mixed-citation>
    </ref>
    <ref id="CR116">
      <label>116.</label>
      <mixed-citation publication-type="other">Hagberg A, Swart P, S Chult D. Exploring network structure, dynamics, and function using networkx. Proceedings of the 7th Python in Science Conference (SciPy2008). 2008;11-15.</mixed-citation>
    </ref>
    <ref id="CR117">
      <label>117.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Virtanen</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Gommers</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Oliphant</surname>
            <given-names>TE</given-names>
          </name>
          <name>
            <surname>Haberland</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Reddy</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cournapeau</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Burovski</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Peterson</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Weckesser</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Bright</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>van der Walt</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Brett</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Millman</surname>
            <given-names>KJ</given-names>
          </name>
          <name>
            <surname>Mayorov</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nelson</surname>
            <given-names>ARJ</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kern</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Larson</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Carey</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Polat</surname>
            <given-names>İ</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Moore</surname>
            <given-names>EW</given-names>
          </name>
          <name>
            <surname>VanderPlas</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Laxalde</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Perktold</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cimrman</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Henriksen</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Quintero</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Archibald</surname>
            <given-names>AM</given-names>
          </name>
          <name>
            <surname>Ribeiro</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Pedregosa</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>van Mulbregt</surname>
            <given-names>P</given-names>
          </name>
          <collab>SciPy 1.0 Contributors</collab>
          <name>
            <surname>Vijaykumar</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bardelli</surname>
            <given-names>AP</given-names>
          </name>
          <name>
            <surname>Rothberg</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hilboll</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kloeckner</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Scopatz</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rokem</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Woods</surname>
            <given-names>CN</given-names>
          </name>
          <name>
            <surname>Fulton</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Masson</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Häggström</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fitzgerald</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Nicholson</surname>
            <given-names>DA</given-names>
          </name>
          <name>
            <surname>Hagen</surname>
            <given-names>DR</given-names>
          </name>
          <name>
            <surname>Pasechnik</surname>
            <given-names>DV</given-names>
          </name>
          <name>
            <surname>Olivetti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wieser</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Silva</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lenders</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wilhelm</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Price</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Ingold</surname>
            <given-names>GL</given-names>
          </name>
          <name>
            <surname>Allen</surname>
            <given-names>GE</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>GR</given-names>
          </name>
          <name>
            <surname>Audren</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Probst</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Dietrich</surname>
            <given-names>JP</given-names>
          </name>
          <name>
            <surname>Silterra</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Webber</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Slavič</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Nothman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Buchner</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kulick</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Schönberger</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>de Miranda Cardoso</surname>
            <given-names>JV</given-names>
          </name>
          <name>
            <surname>Reimer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Harrington</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Rodríguez</surname>
            <given-names>JLC</given-names>
          </name>
          <name>
            <surname>Nunez-Iglesias</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kuczynski</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tritz</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Thoma</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Newville</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kümmerer</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Bolingbroke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tartre</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pak</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>NJ</given-names>
          </name>
          <name>
            <surname>Nowaczyk</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Shebanov</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pavlyk</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Brodtkorb</surname>
            <given-names>PA</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>McGibbon</surname>
            <given-names>RT</given-names>
          </name>
          <name>
            <surname>Feldbauer</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tygier</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sievert</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vigna</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Peterson</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>More</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pudlik</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Oshima</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Pingel</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Robitaille</surname>
            <given-names>TP</given-names>
          </name>
          <name>
            <surname>Spura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>TR</given-names>
          </name>
          <name>
            <surname>Cera</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Leslie</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zito</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Krauss</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Upadhyay</surname>
            <given-names>U</given-names>
          </name>
          <name>
            <surname>Halchenko</surname>
            <given-names>YO</given-names>
          </name>
          <name>
            <surname>Vázquez-Baeza</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>SciPy 1.0: fundamental algorithms for scientific computing in Python</article-title>
        <source>Nat Methods</source>
        <year>2020</year>
        <volume>17</volume>
        <issue>3</issue>
        <fpage>261</fpage>
        <lpage>272</lpage>
        <pub-id pub-id-type="doi">10.1038/s41592-019-0686-2</pub-id>
        <?supplied-pmid 32015543?>
        <pub-id pub-id-type="pmid">32015543</pub-id>
      </element-citation>
    </ref>
    <ref id="CR118">
      <label>118.</label>
      <mixed-citation publication-type="other">Seabold S, Perktold J. Statsmodels: Econometric and statistical modeling with python. Proceedings of the 9th Python in Science Conference. 10.25080/Majora-92bf1922-011.</mixed-citation>
    </ref>
    <ref id="CR119">
      <label>119.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fruchterman</surname>
            <given-names>TMJ</given-names>
          </name>
          <name>
            <surname>Reingold</surname>
            <given-names>EM</given-names>
          </name>
        </person-group>
        <article-title>Graph drawing by force-directed placement</article-title>
        <source>Softw Pract Exp</source>
        <year>1991</year>
        <volume>21</volume>
        <fpage>1129</fpage>
        <lpage>1164</lpage>
        <pub-id pub-id-type="doi">10.1002/spe.4380211102</pub-id>
      </element-citation>
    </ref>
    <ref id="CR120">
      <label>120.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>JW</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Z-X</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Henry</surname>
            <given-names>MD</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>YN</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data</article-title>
        <source>Proc Natl Acad Sci U S A</source>
        <year>2014</year>
        <volume>111</volume>
        <issue>51</issue>
        <fpage>E5593</fpage>
        <lpage>E5601</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1419161111</pub-id>
        <pub-id pub-id-type="pmid">25480548</pub-id>
      </element-citation>
    </ref>
    <ref id="CR121">
      <label>121.</label>
      <mixed-citation publication-type="other">Sterne-Weiler T, Weatheritt RJ, Best A, Ha KCH. Whippet: an efficient method for the detection and quantification of 944 alternative splicing reveals extensive transcriptomic complexity. bioRxiv. 2017. 10.1101/158519</mixed-citation>
    </ref>
    <ref id="CR122">
      <label>122.</label>
      <mixed-citation publication-type="other">Louadi Z. NEASE: A network-based approach for the enrichment of alternative splicing events. Github. 2021. Available from: <ext-link ext-link-type="uri" xlink:href="https://github.com/louadi/NEASE">https://github.com/louadi/NEASE</ext-link>. Accessed 22 Nov 2021.</mixed-citation>
    </ref>
    <ref id="CR123">
      <label>123.</label>
      <mixed-citation publication-type="other">Louadi Z. NEASE: v.1.1.6. Zenodo; 2021. Available from:. 10.5281/zenodo.5653490.</mixed-citation>
    </ref>
    <ref id="CR124">
      <label>124.</label>
      <mixed-citation publication-type="other">Louadi Z. NEASE-tutorials: v1.2. Zenodo; 2021. Available from: 10.5281/ZENODO.5562626</mixed-citation>
    </ref>
  </ref-list>
</back>
